STOCK TITAN

International Battery Metals proposes up to $12M loan

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

International Battery Metals Ltd. (IBATF) reported no service revenue for the quarter ended September 30, 2026, versus $64,000 a year earlier; six-month service revenue was $120,000 versus $71,000, from brine testing. Quarterly net income was $2.168 million with a $2.872 million operating loss, including a $5.042 million gain from the change in warrant-liability fair value; six-month net income was $2.140 million versus $4.666 million.

At September 30, 2026, cash was $7.379 million and working capital $7.9 million; operating activities used $4.364 million in six months. Management said these resources alone would not fund planned operating and capital needs for at least one year, raising substantial doubt about going concern.

On November 13, 2026, the company signed a term sheet with EV Metals 10, LLC, controlled by director Jacob Warnock, for a senior secured facility of up to $12.0 million. Proposed terms include a 5% original issue discount, 10% annual interest, an 18-month maturity and security over all current and future assets and property. Funding is subject to definitive agreements and customary closing conditions, with closing expected in November 2026. Management said the financing plus existing resources would cover at least a year of needs and concluded it alleviates substantial doubt; the loan had not closed when the statements were issued.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 3 points

How the balance works

Positive

  • Minor pointSix-month testing revenue was $120,000, compared with $71,000 a year earlier.

Negative

  • Major pointManagement disclosed substantial doubt absent financing, while the proposed up to $12.0 million loan remained unclosed. 57% of market cap
  • Moderate pointSix-month net income fell to $2.140 million from $4.666 million as warrant fair-value gains narrowed.
  • Minor pointQuarterly service revenue was $0, versus $64,000 a year earlier.

Filing Explained

The balance sheet reports 379,001 thousand common shares outstanding at September 30, 2026, versus 343,033 thousand at March 31; the April placement issued 34,315,465 shares, each with a warrant. Separately, 166,621 thousand warrants remained outstanding; exercise would add shares and reduce existing holders’ percentage ownership.

Six-month service revenue $120,000 Six months ended September 30, 2026; $71,000 in the comparable 2025 period
Quarterly service revenue $0 Three months ended September 30, 2026; $64,000 in the comparable 2025 period
Six-month net income $2.140 million Six months ended September 30, 2026; $4.666 million in the comparable 2025 period
Cash used in operating activities $4.364 million Six months ended September 30, 2026
Cash $7.379 million As of September 30, 2026
Proposed senior secured debt facility Up to $12.0 million Term sheet executed November 13, 2026; subject to definitive agreements and customary closing conditions
Interest rate 10% per annum Proposed debt facility
Original issue discount 5% Proposed debt facility
warrant liability financial
"gain from the change in warrant-liability fair value"
Warrant liability is the financial obligation a company records when it grants warrants—special options giving the holder the right to buy company shares at a set price in the future. It matters to investors because changes in this liability can affect a company's reported earnings and overall financial health, similar to how a pending contract can influence a company's future value.
going concern financial
"substantial doubt about going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
Original Issue Discount financial
"subject to an Original Issue Discount of 5%"
Original issue discount (OID) is the difference between a debt security’s face value and the lower price at which it is first sold, treated as additional interest that accrues over the life of the instrument. For investors it matters because OID raises the effective yield and changes taxable income and the holding’s cost basis over time — think of buying a $100 voucher for $90 and recognizing the $10 gain as earned interest as the voucher approaches maturity.
working capital financial
"cash and working capital"
Working capital is the money a business has available to cover its daily expenses, like paying bills and buying supplies. It’s like the cash in your wallet that helps you handle everyday costs; having enough ensures the business can operate smoothly without running into money shortages.
Black-Scholes option pricing model financial
"estimated using the Black-Scholes option pricing model"
The Black–Scholes option pricing model is a mathematical formula that estimates the fair price of an option by combining the current stock price, strike price, time until expiration, the expected size of price swings (volatility), and the prevailing safe interest rate. Investors use it like a weather forecast or recipe: it provides a consistent way to value option contracts so traders can compare prices, decide if an option is under- or over-priced, and manage risk.
weighted average exercise price financial
"weighted average exercise price of the warrants"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What revenue did IBATF report for the quarter and six months?

IBATF reported no service revenue for the quarter ended September 30, 2026, compared with $64,000 a year earlier; six-month service revenue was $120,000 versus $71,000. The six months ended September 30, 2026 included three preliminary brine-testing transactions.

What are the terms of IBATF’s proposed debt facility?

The proposed senior secured facility is for up to $12.0 million. Its term sheet calls for a 5% original issue discount, 10% annual interest and an 18-month maturity, secured by all current and future assets and property. Funding is subject to definitive agreements and customary closing conditions; the parties expected to close in November 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
falseQ2March 310001786318202700-0000000http://fasb.org/us-gaap/2026#LeaseholdImprovementsMemberOneOnehttp://fasb.org/srt/2026#ChiefExecutiveOfficerMemberhttp://fasb.org/us-gaap/2026#Liabilitieshttp://fasb.org/us-gaap/2026#LiabilitiesUnlimitedOne0001786318us-gaap:RestrictedStockUnitsRSUMemberus-gaap:SubsequentEventMember2026-10-022026-10-020001786318srt:DirectorMemberibatf:OmnibusEquityIncentivePlanMemberibatf:RestrictedShareAwardsMember2025-12-182025-12-180001786318us-gaap:CapitalUnitsMember2025-09-300001786318ibatf:OptionsToPurchaseCommonSharesMember2026-07-012026-09-300001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMember2026-06-192026-06-190001786318us-gaap:CommonStockMember2025-03-310001786318us-gaap:RestrictedStockUnitsRSUMember2025-07-012025-09-300001786318us-gaap:WarrantMember2025-04-012025-09-300001786318us-gaap:RetainedEarningsMember2025-06-300001786318ibatf:TwoThousandTwentyFiveLetterAgreementMember2026-02-232026-02-230001786318ibatf:RestrictedShareAwardsMember2025-04-012025-09-300001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMember2025-06-020001786318us-gaap:CommonStockMember2026-03-310001786318ibatf:EncompassMemberus-gaap:PrivatePlacementMember2024-05-062024-05-0600017863182026-11-090001786318ibatf:RestrictedShareUnitPlanMembersrt:MaximumMember2020-11-252020-11-250001786318ibatf:RestrictedShareAwardsMember2026-07-012026-09-300001786318ibatf:RestrictedShareUnitPlanMember2025-12-172025-12-310001786318ibatf:OptionsToPurchaseCommonSharesMember2025-07-012025-09-300001786318ibatf:EncompassMember2024-05-062024-05-060001786318us-gaap:WarrantMember2026-03-3100017863182026-06-300001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMember2025-04-070001786318us-gaap:OfficeEquipmentMember2026-09-3000017863182026-04-012026-09-300001786318us-gaap:ServiceMember2026-04-012026-09-300001786318us-gaap:IntellectualPropertyMember2025-04-012026-03-310001786318us-gaap:WarrantMember2025-04-012025-09-300001786318us-gaap:OfficeEquipmentMember2026-03-310001786318us-gaap:RestrictedStockUnitsRSUMemberibatf:RestrictedStockUnitPlanMember2023-12-170001786318us-gaap:RetainedEarningsMember2025-07-012025-09-300001786318ibatf:OmnibusEquityIncentivePlanMembersrt:MaximumMember2025-12-172025-12-170001786318us-gaap:CommonStockMember2025-09-300001786318ibatf:WarrantsToPurchaseCommonSharesMember2025-07-012025-09-300001786318us-gaap:PrivatePlacementMember2024-06-192024-06-190001786318us-gaap:RestrictedStockUnitsRSUMember2025-07-012025-09-300001786318ibatf:OptionsToPurchaseCommonSharesMember2026-04-012026-09-300001786318us-gaap:CommonStockMember2025-04-012025-09-300001786318us-gaap:CommonStockMember2026-04-012026-09-300001786318us-gaap:CapitalUnitsMember2025-04-012025-09-300001786318us-gaap:WarrantMemberus-gaap:FairValueInputsLevel2Member2026-09-300001786318us-gaap:ShareBasedCompensationAwardTrancheTwoMembersrt:MinimumMember2026-02-042026-02-040001786318ibatf:EncompassMember2025-07-202025-07-200001786318ibatf:TwoThousandTwentyFiveLetterAgreementMember2026-04-290001786318ibatf:PlanoMember2026-04-012026-09-300001786318srt:MaximumMember2025-07-202025-07-200001786318us-gaap:CapitalUnitsMember2025-06-300001786318us-gaap:EquipmentMember2026-03-310001786318ibatf:PlanoMember2026-09-300001786318us-gaap:IntellectualPropertyMember2026-09-300001786318ibatf:JacobWarnockMemberibatf:TwoThousandTwentyFiveLetterAgreementMember2026-02-232026-02-230001786318us-gaap:WarrantMember2026-04-012026-09-300001786318us-gaap:EquipmentMember2026-09-3000017863182023-03-3000017863182025-03-310001786318us-gaap:RestrictedStockUnitsRSUMember2025-04-012025-09-300001786318ibatf:Share-BasedPaymentArrangementTrancheFourMember2026-02-042026-02-040001786318us-gaap:CommonStockMember2025-06-300001786318us-gaap:CapitalUnitsMember2026-03-310001786318ibatf:TwoThousandTwentyFiveLetterAgreementMember2025-03-022025-03-020001786318ibatf:RestrictedShareAwardsMember2026-04-012026-09-300001786318us-gaap:IntellectualPropertyMember2026-03-310001786318us-gaap:ServiceMember2026-07-012026-09-300001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMember2025-10-022025-10-020001786318us-gaap:RetainedEarningsMember2026-04-012026-09-300001786318us-gaap:WarrantMemberus-gaap:FairValueInputsLevel2Member2026-03-310001786318ibatf:EVMetalsVILLCMember2024-05-062024-05-060001786318us-gaap:EmployeeStockOptionMember2026-07-012026-09-300001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2026-02-042026-02-040001786318us-gaap:EmployeeStockOptionMember2025-04-012025-09-300001786318ibatf:EVMetalsVILLCMembersrt:DirectorMemberus-gaap:PrivatePlacementMember2024-06-192024-06-190001786318ibatf:SecondClosingMember2025-04-112025-04-110001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMember2025-06-022025-06-0200017863182025-07-012025-09-300001786318ibatf:ComputerEquipmentAndFurnitureAndFixturesMember2026-09-300001786318us-gaap:PrivatePlacementMember2024-05-062024-05-060001786318us-gaap:WarrantMember2026-07-012026-09-3000017863182025-12-172025-12-310001786318us-gaap:RetainedEarningsMember2025-03-310001786318us-gaap:CommonStockMember2026-07-012026-09-300001786318ibatf:TwoThousandTwentyFiveLetterAgreementMember2026-04-292026-04-290001786318ibatf:TermLoanMembersrt:ScenarioForecastMembersrt:MaximumMember2026-11-300001786318us-gaap:ShareBasedCompensationAwardTrancheTwoMember2026-04-012026-09-300001786318us-gaap:ServiceMember2025-07-012025-09-300001786318ibatf:WarrantsToPurchaseCommonSharesMember2026-04-012026-09-300001786318us-gaap:PatentsMember2026-04-012026-09-300001786318ibatf:EncompassMember2025-07-200001786318us-gaap:PrivatePlacementMember2024-05-060001786318ibatf:JacobWarnockMemberibatf:TwoThousandTwentyFiveLetterAgreementMember2025-10-302025-10-300001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2026-07-012026-09-300001786318ibatf:Share-BasedPaymentArrangementTrancheSixMember2026-02-042026-02-040001786318ibatf:TwoThousandTwentyFiveLetterAgreementMember2025-10-300001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMember2025-04-072025-04-070001786318ibatf:OmnibusEquityIncentivePlanMemberibatf:RestrictedShareAwardsMember2026-09-300001786318ibatf:ModularDirectLithiumExtractionMember2026-09-300001786318ibatf:PlantMembersrt:MinimumMember2026-09-300001786318us-gaap:RetainedEarningsMember2026-09-300001786318ibatf:AssetPurchaseAgreementMember2018-04-120001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMember2026-05-192026-05-190001786318us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMembersrt:ManagementMember2026-02-042026-02-0400017863182025-12-170001786318ibatf:StockOptionPlanMemberus-gaap:EmployeeStockOptionMember2023-12-152023-12-150001786318us-gaap:SecuredDebtMembersrt:ScenarioForecastMember2026-11-300001786318us-gaap:RetainedEarningsMember2026-07-012026-09-300001786318us-gaap:RestrictedStockUnitsRSUMember2025-04-012025-09-3000017863182025-03-312025-03-310001786318us-gaap:ShareBasedCompensationAwardTrancheTwoMembersrt:MaximumMember2026-02-042026-02-040001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2026-04-012026-09-3000017863182025-09-300001786318us-gaap:WarrantMemberus-gaap:FairValueInputsLevel1Member2026-09-300001786318us-gaap:RetainedEarningsMember2025-04-012025-09-3000017863182025-04-012025-12-310001786318us-gaap:CapitalUnitsMember2025-03-310001786318us-gaap:WarrantMember2026-09-300001786318ibatf:TwoThousandTwentyFiveLetterAgreementMember2025-02-282025-02-280001786318ibatf:OmnibusEquityIncentivePlanMemberibatf:BoardOfDirectorsMemberibatf:RestrictedShareAwardsMember2025-12-180001786318us-gaap:WarrantMemberus-gaap:FairValueInputsLevel1Member2026-03-310001786318us-gaap:CapitalUnitsMember2025-07-012025-09-300001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2026-04-012026-09-300001786318us-gaap:WarrantMember2026-09-300001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMember2026-04-012026-09-300001786318ibatf:OmnibusEquityIncentivePlanMemberibatf:BoardOfDirectorsMemberibatf:RestrictedShareAwardsMember2025-12-182025-12-180001786318us-gaap:EmployeeStockOptionMember2026-04-012026-09-300001786318us-gaap:PatentsMember2025-04-012026-03-310001786318us-gaap:EmployeeStockOptionMemberibatf:PriorPlansMember2025-12-172025-12-310001786318ibatf:OptionsToPurchaseCommonSharesMember2025-04-012025-09-300001786318us-gaap:RestrictedStockUnitsRSUMember2026-07-012026-09-3000017863182026-03-310001786318us-gaap:ShareBasedCompensationAwardTrancheThreeMember2026-02-042026-02-040001786318ibatf:TwoThousandTwentyFiveLetterAgreementMember2026-02-2300017863182018-11-012018-11-300001786318us-gaap:CommonStockMember2026-06-300001786318ibatf:Share-BasedPaymentArrangementTrancheFiveMember2026-02-042026-02-040001786318us-gaap:PrivatePlacementMember2024-06-190001786318ibatf:MilestoneSharesMemberibatf:AssetPurchaseAgreementMember2018-04-120001786318srt:MaximumMember2026-09-3000017863182026-09-300001786318ibatf:EVMetalsVILLCMemberus-gaap:PrivatePlacementMember2024-06-192024-06-190001786318ibatf:TwoThousandTwentyFiveLetterAgreementMember2025-10-302025-10-300001786318us-gaap:WarrantMember2025-07-012025-09-300001786318us-gaap:RetainedEarningsMember2026-06-300001786318ibatf:TwoThousandTwentyFiveLetterAgreementMember2025-03-312025-03-310001786318us-gaap:ServiceMember2025-04-012025-09-300001786318ibatf:RestrictedShareAwardsMember2025-07-012025-09-300001786318us-gaap:PatentsMember2026-03-310001786318us-gaap:RetainedEarningsMember2025-09-300001786318us-gaap:WarrantMember2026-03-310001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2026-07-012026-09-300001786318us-gaap:CapitalUnitsMember2026-09-3000017863182018-11-300001786318ibatf:WarrantsToPurchaseCommonSharesMember2025-04-012025-09-300001786318ibatf:FirstClosingMember2025-03-312025-03-310001786318ibatf:ModularDirectLithiumExtractionMember2026-03-310001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMemberibatf:Share-BasedPaymentArrangementTrancheFourMember2026-04-012026-09-3000017863182023-03-302023-03-300001786318ibatf:Share-BasedPaymentArrangementTrancheFourMember2026-04-292026-04-290001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMember2025-11-032025-11-030001786318ibatf:AssetPurchaseAgreementMember2018-04-122018-04-120001786318currency:CADibatf:ForeignCurrencyRiskMember2026-09-300001786318us-gaap:CommonStockMember2026-09-300001786318ibatf:TermLoanMembersrt:ScenarioForecastMember2026-11-300001786318ibatf:JacobWarnockMemberibatf:TwoThousandTwentyFiveLetterAgreementMember2026-04-292026-04-290001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMemberibatf:Share-BasedPaymentArrangementTrancheFourMember2026-07-012026-09-300001786318us-gaap:EmployeeStockOptionMember2025-07-012025-09-300001786318us-gaap:SecuredDebtMembersrt:ScenarioForecastMembersrt:MaximumMember2026-11-300001786318us-gaap:IntellectualPropertyMember2026-04-012026-09-300001786318us-gaap:CapitalUnitsMember2026-06-300001786318us-gaap:PatentsMember2026-09-300001786318us-gaap:ConstructionInProgressMember2026-03-310001786318us-gaap:RestrictedStockUnitsRSUMember2026-04-012026-09-300001786318us-gaap:CommonStockMember2025-07-012025-09-300001786318us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2026-09-300001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMember2026-07-012026-09-300001786318ibatf:TwoThousandTwentyFiveLetterAgreementMember2025-04-112025-04-110001786318us-gaap:RetainedEarningsMember2026-03-3100017863182025-04-112025-04-1100017863182025-06-300001786318ibatf:EncompassMemberus-gaap:PrivatePlacementMember2024-06-192024-06-190001786318us-gaap:ShareBasedCompensationAwardTrancheTwoMember2026-02-042026-02-0400017863182025-03-020001786318ibatf:WarrantsToPurchaseCommonSharesMember2026-07-012026-09-300001786318us-gaap:WarrantMember2026-04-012026-09-300001786318us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMembersrt:ManagementMember2026-07-012026-09-3000017863182026-07-012026-09-300001786318us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2026-03-310001786318us-gaap:CapitalUnitsMember2026-04-012026-09-3000017863182024-04-012025-03-310001786318us-gaap:ShareBasedCompensationAwardTrancheTwoMember2026-04-292026-04-290001786318us-gaap:ConstructionInProgressMember2026-09-300001786318us-gaap:IntellectualPropertyMemberibatf:AssetPurchaseAgreementMember2018-04-122018-04-120001786318us-gaap:RestrictedStockUnitsRSUMemberibatf:PriorPlansMember2025-12-172025-12-310001786318ibatf:StockOptionPlanMemberus-gaap:EmployeeStockOptionMember2023-12-150001786318ibatf:EVMetalsVILLCMemberus-gaap:PrivatePlacementMember2024-05-062024-05-060001786318ibatf:PlantMembersrt:MaximumMember2026-09-300001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMember2025-02-122025-02-120001786318us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMember2026-05-142026-05-1400017863182025-04-012025-09-3000017863182025-04-012026-03-310001786318us-gaap:CapitalUnitsMember2026-07-012026-09-30iso4217:USDxbrli:sharesxbrli:pureiso4217:CADxbrli:sharesibatf:Segmentxbrli:sharesiso4217:USD

Table of Contents

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2026

OR

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from XXXXXXXX XX, XXXX to XXXXXXXX XX, XXXX

Commission File Number: 333-286616

 

img260925486_0.jpg

INTERNATIONAL BATTERY METALS LTD.

(Exact Name of Registrant as Specified in its Charter)

 

 

British Columbia, Canada

Not Applicable

(State or Other Jurisdiction of
Incorporation or Organization)

(I.R.S. Employer
Identification Number)

12 Greenway Plaza, Suite 1100
Houston, Texas

77046

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (832) 683-8839

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☒

Smaller reporting company

☒

Emerging growth company

 

☒

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 9, 2026, the registrant had 379,183,970 common shares, no par value per share, outstanding.

 

 


Table of Contents

 

Table of Contents

 

 

 

Page

 

 

 

PART I.

FINANCIAL INFORMATION

1

 

 

 

Item 1.

Condensed Consolidated Financial Statements

1

 

Notes to the Condensed Consolidated Financial Statements

5

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

20

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

26

Item 4.

Controls and Procedures

27

 

 

 

PART II.

OTHER INFORMATION

28

 

 

 

Item 1A.

Risk Factors

28

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

28

Item 3.

Defaults Upon Senior Securities

28

Item 4.

Mine Safety Disclosures

28

Item 5.

Other Information

28

Item 6.

Exhibits

29

Signatures

30

 

i


Table of Contents

 

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

International Battery Metals Ltd.

Condensed Consolidated Balance Sheets

As of September 30, 2026 and March 31, 2026

(In thousands)

 

 

September 30,

 

 

March 31,

 

 

 

2026

 

 

2026

 

 

 

(Unaudited)

 

 

 

 

Assets

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash

 

$

7,379

 

 

$

9,187

 

Accounts receivable, net

 

 

16

 

 

 

90

 

Supply inventory

 

 

1,061

 

 

 

1,061

 

Other current assets

 

 

385

 

 

 

251

 

Total current assets

 

 

8,841

 

 

 

10,589

 

 

 

 

 

 

 

 

Plant and equipment, net

 

 

25,992

 

 

 

26,842

 

Intangible assets, net

 

 

1,652

 

 

 

2,190

 

Right of use asset

 

 

93

 

 

 

141

 

Total assets

 

$

36,578

 

 

$

39,762

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Accounts payable

 

$

388

 

 

$

395

 

Accrued liabilities

 

 

448

 

 

 

892

 

Lease obligation, current

 

 

104

 

 

 

99

 

Total current liabilities

 

 

940

 

 

 

1,386

 

 

 

 

 

 

 

Warrant liability

 

 

4,749

 

 

 

9,968

 

Lease obligation, long-term

 

 

—

 

 

 

44

 

Total liabilities

 

 

5,689

 

 

 

11,398

 

 

 

 

 

 

 

Commitments and contingencies (Note 15)

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders' equity

 

 

 

 

 

 

Share capital, no par 379,001 and 343,033 common shares issued and outstanding, respectively, as of September 30, 2026 and March 31, 2026, respectively

 

 

68,193

 

 

 

67,808

 

Accumulated deficit

 

 

(37,304

)

 

 

(39,444

)

Total shareholders' equity

 

 

30,889

 

 

 

28,364

 

Total liabilities and shareholders' equity

 

$

36,578

 

 

$

39,762

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

1


Table of Contents

 

International Battery Metals Ltd.

Condensed Consolidated Statements of Income (Loss)(Unaudited)

For the Three and Six Months Ended September 30, 2026 and 2025

(In thousands, except per share amounts)

 

 

Three Months Ended September 30,

 

 

Six Months Ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

REVENUE

 

 

 

 

 

 

 

 

 

 

 

 

Service

 

 

—

 

 

$

64

 

 

$

120

 

 

$

71

 

Total Revenue

 

 

—

 

 

 

64

 

 

 

120

 

 

 

71

 

 

 

 

 

 

 

 

 

 

 

 

 

COST OF REVENUE

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

—

 

 

 

11

 

 

 

3

 

 

 

12

 

Gross margin

 

 

—

 

 

 

53

 

 

 

117

 

 

 

59

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATING COSTS AND EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

Operating costs, excluding depreciation

 

 

485

 

 

 

509

 

 

 

894

 

 

 

1,109

 

Selling, general and administrative expenses, excluding depreciation

 

 

1,614

 

 

 

2,197

 

 

 

3,457

 

 

 

4,474

 

Amortization of intangible assets

 

 

269

 

 

 

269

 

 

 

538

 

 

 

538

 

Depreciation

 

 

504

 

 

 

504

 

 

 

1,007

 

 

 

1,002

 

Operating loss

 

 

(2,872

)

 

 

(3,426

)

 

 

(5,779

)

 

 

(7,064

)

Loss on warrants modification

 

 

—

 

 

 

(2,444

)

 

 

—

 

 

 

(2,444

)

Change in fair value of warrant liability

 

 

5,042

 

 

 

8,848

 

 

 

7,925

 

 

 

14,171

 

Other income (loss)

 

 

(2

)

 

 

—

 

 

 

(6

)

 

 

3

 

Net income (loss) before income tax provision

 

 

2,168

 

 

 

2,978

 

 

 

2,140

 

 

 

4,666

 

Net income (loss)

 

$

2,168

 

 

$

2,978

 

 

$

2,140

 

 

$

4,666

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share, basic

 

$

0.01

 

 

$

0.01

 

 

$

0.01

 

 

$

0.02

 

Net income (loss) per share, diluted

 

$

0.01

 

 

$

0.01

 

 

$

0.01

 

 

$

0.02

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding, basic

 

 

374,391

 

 

 

286,976

 

 

 

368,208

 

 

 

279,059

 

Weighted average shares outstanding, diluted

 

 

382,748

 

 

 

291,632

 

 

 

375,707

 

 

 

284,140

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

2


Table of Contents

 

International Battery Metals Ltd.

Condensed Consolidated Statements of Cash Flows (Unaudited)

For the Six Months Ended September 30, 2026 and 2025

(In thousands)

 

 

Six Months Ended September 30,

 

 

 

2026

 

 

2025

 

CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES

 

 

 

 

 

 

Net income (loss)

 

$

2,140

 

 

$

4,666

 

Adjustments to reconcile net income (loss) to cash used in operating activities:

 

 

 

 

 

 

Share-based compensation

 

 

493

 

 

 

137

 

Amortization of intangible assets

 

 

538

 

 

 

538

 

Depreciation

 

 

1,007

 

 

 

1,002

 

Change in fair value of warrant liability

 

 

(7,925

)

 

 

(14,171

)

Loss on warrants modification

 

 

—

 

 

 

2,444

 

Changes in assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

74

 

 

 

(132

)

Prepaid expenses

 

 

62

 

 

 

(120

)

Lease liability

 

 

9

 

 

 

1

 

Trade payables and other liabilities

 

 

(762

)

 

 

(126

)

Net cash used in operating activities

 

 

(4,364

)

 

 

(5,761

)

 

 

 

 

 

 

CASH USED IN INVESTING ACTIVITIES

 

 

 

 

 

 

Purchase of equipment

 

 

(41

)

 

 

(359

)

Net cash used in investing activities

 

 

(41

)

 

 

(359

)

 

 

 

 

 

 

CASH PROVIDED BY (USED IN) BY FINANCING ACTIVITIES

 

 

 

 

 

 

Proceeds from private placement of shares and warrants

 

 

2,771

 

 

 

5,000

 

Share issuance costs

 

 

(155

)

 

 

(194

)

Payments for taxes withheld of vested stock awards

 

 

(19

)

 

 

-

 

Net cash provided by financing activities

 

 

2,597

 

 

 

4,806

 

 

 

 

 

 

 

Net change in cash

 

 

(1,808

)

 

 

(1,314

)

Beginning cash balance

 

 

9,187

 

 

 

10,737

 

Ending cash balance

 

$

7,379

 

 

$

9,423

 

 

 

 

 

 

 

Supplemental disclosures of non-cash transactions:

 

 

 

 

 

 

Equipment purchases included in trade payables

 

$

116

 

 

$

2

 

Shares issued in debt settlement

 

 

—

 

 

 

679

 

Private placement proceeds allocated to warrant liability

 

 

2,705

 

 

 

4,647

 

Accounts receivable settled through share cancellation

 

 

—

 

 

 

75

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3


Table of Contents

 

International Battery Metals Ltd.

Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited)

For the Three and Six Months Ended September 30, 2026 and 2025

(In thousands)

 

 

Common

 

 

Share

 

 

Accumulated

 

 

Total
Shareholders'

 

 

 

Shares

 

 

Capital

 

 

Deficit

 

 

Equity

 

Balance as of March 31, 2026

 

 

343,033

 

 

$

67,808

 

 

$

(39,444

)

 

$

28,364

 

Private placements of shares

 

 

34,315

 

 

 

66

 

 

 

—

 

 

 

66

 

Shares issued for restricted stock units

 

 

1,850

 

 

 

—

 

 

 

—

 

 

 

—

 

Shares issued for restricted stock awards

 

 

—

 

 

 

128

 

 

 

—

 

 

 

128

 

Shares cancelled

 

 

(197

)

 

 

(19

)

 

 

—

 

 

 

(19

)

Share-based compensation

 

 

—

 

 

 

365

 

 

 

—

 

 

 

365

 

Share issuance costs

 

 

—

 

 

 

(155

)

 

 

—

 

 

 

(155

)

Net income for the period

 

 

—

 

 

 

—

 

 

 

2,140

 

 

 

2,140

 

Balance as of September 30, 2026

 

 

379,001

 

 

$

68,193

 

 

$

(37,304

)

 

$

30,889

 

 

 

 

Common

 

 

Share

 

 

Accumulated

 

 

Total
Shareholders'

 

 

 

Shares

 

 

Capital

 

 

Deficit

 

 

Equity

 

Balance as of June 30, 2026

 

 

378,001

 

 

$

68,069

 

 

$

(39,472

)

 

$

28,597

 

Shares issued for restricted stock units

 

 

1,000

 

 

 

—

 

 

 

—

 

 

 

—

 

Share-based compensation

 

 

—

 

 

 

124

 

 

 

—

 

 

 

124

 

Net income for the period

 

 

—

 

 

 

—

 

 

 

2,168

 

 

 

2,168

 

Balance as of September 30, 2026

 

 

379,001

 

 

$

68,193

 

 

$

(37,304

)

 

$

30,889

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Common

 

 

Share

 

 

Accumulated

 

 

Shareholders'

 

 

 

Shares

 

 

Capital

 

 

Deficit

 

 

Equity

 

Balance as of March 31, 2025

 

 

268,992

 

 

$

66,156

 

 

$

(39,566

)

 

$

26,590

 

Private placements of shares

 

 

28,111

 

 

 

1,032

 

 

 

—

 

 

 

1,032

 

Shares cancelled

 

 

(300

)

 

 

(75

)

 

 

—

 

 

 

(75

)

Share-based compensation

 

 

—

 

 

 

137

 

 

 

—

 

 

 

137

 

Share issuance costs

 

 

—

 

 

 

(194

)

 

 

—

 

 

 

(194

)

Subscriptions received

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Net income for the period

 

 

—

 

 

 

—

 

 

 

4,666

 

 

 

4,666

 

Balance as of September 30, 2025

 

 

296,803

 

 

$

67,056

 

 

$

(34,900

)

 

$

32,156

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Common

 

 

Share

 

 

Accumulated

 

 

Shareholders'

 

 

 

Shares

 

 

Capital

 

 

Deficit

 

 

Equity

 

Balance as of June 30, 2025

 

 

271,338

 

 

$

65,827

 

 

$

(37,878

)

 

$

27,949

 

Private placements of shares

 

 

25,765

 

 

 

1,024

 

 

 

—

 

 

 

1,024

 

Shares cancelled

 

 

(300

)

 

 

201

 

 

 

—

 

 

 

201

 

Share-based compensation

 

 

—

 

 

 

137

 

 

 

—

 

 

 

137

 

Share issuance costs

 

 

—

 

 

 

(133

)

 

 

—

 

 

 

(133

)

Net income for the period

 

 

—

 

 

 

—

 

 

 

2,978

 

 

 

2,978

 

Balance as of September 30, 2025

 

 

296,803

 

 

$

67,056

 

 

$

(34,900

)

 

$

32,156

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4


Table of Contents

 

International Battery Metals Ltd.

Notes to the Condensed Consolidated Financial Statements (Unaudited)

For the Three and Six Months Ended September 30, 2026 and 2025

1.
Organization and Description of the Business

International Battery Metals Ltd. (the “Company”) was incorporated under the Business Corporations Act (British Columbia) on July 29, 2010. The Company trades on the TSX Venture Exchange in Canada under the stock symbol “IBAT”. The Company also trades on the Over-The-Counter Markets (“OTC”) in the United States of America under the stock symbol “IBATF”. The Company’s registered and records office is located at 300 - 638 Smithe Street, Vancouver, BC V6B 1P3.

The Company is an advanced technology and manufacturing business focused on environmentally responsible methods of extracting lithium compounds from brine. The Company seeks to provide its technology and equipment to holders of resource properties such as oilfield brines, subsurface brine aquifers and industrial customers who have lithium rich brine by products from their operations. The Company’s proprietary extraction process is environmentally friendly, low cost and able to produce high-quality commercial grade lithium chloride products.

The Company’s current operations consist of the development of a modular direct lithium extraction plant (“MDLE Plant”) which can be rapidly deployed and assembled onsite at a customer's property. The MDLE Plant is designed to process brine solutions to extract lithium chloride which can be further processed (refined) into lithium carbonate and used for industrial purposes or as a battery component. The Company constructed the first demonstration MDLE Plant in Lake Charles, Louisiana where it performed feasibility testing and was made available for demonstration to potential customers. The Company is currently marketing the current MDLE Plant to potential customers and developing the next generation of our MDLE Plant technology which we anticipate could provide customers with additional options for processing brine solutions and increasing lithium chloride production.

2.
Basis of Presentation

Basis of Presentation and Principles of Consolidation

The Company’s condensed consolidated financial statements have been prepared in accordance with the accounting principles generally accepted in the United States of America (“GAAP”) on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future. The condensed consolidated statements furnished reflect all normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of results for the interim periods presented. The condensed consolidated financial statements include the results of the Company and its subsidiaries. A subsidiary is consolidated from the date upon which control is acquired by the Company and all intercompany transactions and balances have been eliminated. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2026. The results of operations for the three and six months ended September 30, 2026 are not necessarily indicative of the results to be expected for the full fiscal year.

Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation.

Functional Currency

The Company has determined that the U.S. dollar is the functional currency for all the Company’s operations since the Company conducts the significant majority of its operations through its U.S subsidiary, IBAT USA, Inc., compensates all of its corporate officers and the board of directors in U.S. dollars and historically the majority of its expenditures are also denominated in U.S. dollars. The Company has maintained limited amounts of Canadian dollars to cover administration expenses associated with the Company’s registration in Canada. The Company has limited exposure to exchange rate fluctuations, and for the three months ended September 30, 2026 and 2025, the Company recognized net transaction losses of approximately $2,000 and $6,000, respectively, related to currency exchange rates. For the six months ended September 30, 2026 and 2025, the Company recognized net transaction losses of approximately $6,000 and $7,000, respectively, related to currency exchange rates.

 

Liquidity and Going Concern

The Company has incurred recurring operating losses and negative cash flows from operations since inception, and as of September 30, 2026 has an accumulated deficit of approximately $37.3 million. For the six months ended September 30, 2026, net cash used in operating activities was approximately $4.4 million. As of September 30, 2026, the Company had cash and cash equivalents of approximately $7.4 million and working capital of approximately $7.9 million. The Company expects to continue to incur operating losses and negative operating cash flows for the foreseeable future. It also expects to make significant capital

 

5


Table of Contents

 

expenditures for the continued development and deployment of its existing MDLE plant and for the construction and deployment of a mobile MDLE pilot plant.

In accordance with ASC 205-40, Going Concern, management evaluated whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued. Management determined that the Company’s existing cash and working capital, without additional financing, would not be sufficient to fund its planned operating and capital expenditures, including financial obligations that will become due for that period. These conditions raised substantial doubt about the Company’s ability to continue as a going concern.

On November 13, 2026, the Company executed a term sheet with EV Metals 10, LLC (a company controlled by Jacob Warnock, a director of the Company and a related party) for a senior secured debt facility of up to $12.0 million ("Term Loan"). Under the proposed terms, borrowings under the Term Loan would be subject to an Original Issue Discount of 5%, bear interest at 10% per annum, matures 18 months from execution, and be secured by all current and future assets and property of the Company. In the event that the Term Loan is prepaid in the first 12 month, the Company would be subject to a make whole payment on interest assuming the debt was outstanding the entire term of the loan. From months 13 through 18, in the event of a prepayment, the Company would pay a 10% premium on all principal outstanding. EV Metals 10, LLC has committed to fund the facility, subject to the execution of definitive agreements and customary closing conditions, and the parties expect to close the transaction in November 2026.The Company intends to use the proceeds to fund the continued development and deployment of its existing MDLE plant, the construction and deployment of its mobile MDLE pilot plant, and general working capital.

Management believes it is probable that the financing will be completed and that the proceeds, together with existing cash and working capital, will be sufficient to fund the Company’s operating and capital requirements for at least one year from the date these condensed consolidated financial statements are issued. Accordingly, management has concluded that its plans alleviate the substantial doubt about the Company’s ability to continue as a going concern. The Company expects to require additional financing in the future to fund its operations and growth. It has historically funded operations primarily through private placements of units comprising common shares and warrants.

3.
Summary of Significant Accounting Policies

Cash

Cash consists of deposits with financial institutions.

Revenue

During the six months ended September 30, 2026 the Company had three revenue transactions for preliminary brine testing. During the three months ended September 30, 2026 the Company had no revenue transactions.

The Company follows the five steps approach for revenue recognition under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606 Revenue from Contracts with Customers ("ASC 606): (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. Billings to customers for which services are not rendered are considered deferred revenue. The Company’s revenue is recognized when it satisfies a single performance obligation by transferring control of its products or providing services to a customer. The Company’s general payment terms are short-term in duration. The Company does not have significant financing components or payment terms.

Supply Inventory

Inventories are carried at the lower of cost and net realizable value and primarily consist of spare parts for the MDLE Plant. The Company determines the costs for inventory using the weighted average cost method. There were no adjustments made to inventory valuation during the three and six months ended September 30, 2026 and 2025.

Plant and Equipment

Equipment is recorded at cost, less accumulated depreciation and impairment losses. The Company provides for depreciation over the expected useful life of the assets. No depreciation is recorded on assets prior to their initial commencement of operations. Costs include expenditures to acquire or construct an asset, including the preparation of an asset to commence operations, installation, commissioning, and certification costs. Subsequent costs are capitalized, either to the asset’s carrying amount or recognized as a separate asset when it is probable that the Company will derive future economic benefits, generally from extending the assets’ life or enhancing its’ productive capacity. The estimated useful lives of assets are reviewed by management and adjusted if necessary. Repair and maintenance costs are expense as incurred.

The Company substantially completed the construction of its first MDLE Plant in November 2021. As the MDLE Plant did not commence commercial operations, the Company did not initiate the recognition of depreciation on the MDLE Plant until June 19, 2024, when it was briefly placed into service at US Magnesium. Prior to commencement of operations, the Company

 

6


Table of Contents

 

utilized the MDLE Plant to perform feasibility studies and as a demonstration plant for potential customers. During these feasibility studies and demonstrations, based on the results, the Company continued to make enhancements to the MDLE Plant and capitalize the associated costs.

Fixed assets include tangible assets with useful lives that exceed one year and valued at historical cost-plus costs incurred to place that asset into service. Subsequent expenditures are only capitalized if it will increase the future economic benefit of the asset. Subsequent expenditures that do not increase the future economic benefit are expense as incurred. Depreciation is recorded using the straight-line method over the useful life of the estimated useful lives of the assets as follows:

 

•

Computer equipment and furniture and fixtures

5 years

 

•

Leasehold improvements

remaining term of lease

 

•

Plant

15 – 20 years

Intangible Assets

Intangible assets include patented technology acquired by the Company and have finite useful lives measured at cost less accumulated amortization and any accumulated impairment losses. Subsequent expenditure is capitalized only when it increases the future economic benefits embodied in the specific asset to which it relates. All other expenditures are expense as incurred. Amortization is recorded using the straight-line method and is intended to amortize the cost of the assets over their estimated useful lives as follows:

 

•

Patents

20 years

 

•

Intellectual property

10 years

Amortization methods, useful lives and residual values are reviewed at each reporting date and adjusted, if appropriate.

Fair Value of Financial Instruments

The Company has classified fair value measurements of its financial instruments using a fair value hierarchy that reflects the significance of inputs used in making the measurements as follows:

•
Level 1 fair value measurements are those derived from quoted prices in active markets for identical assets or liabilities.
•
Level 2 fair value measurements are those derived from inputs other than quoted prices included within Level 1, that are observable either directly or indirectly.
•
Level 3 fair value measurements are those derived from valuation techniques that include inputs that are not based on observable market data.

The fair value of financial assets and financial liabilities at amortized cost is determined based on discounted cash flow analysis or using prices from observable current market transactions. The Company considers that the carrying amount of all its financial assets and financial liabilities recognized at amortized cost in the condensed consolidated financial statements approximates their fair value due to the demand nature or short-term maturity of these instruments. Cash is measured using level 1 of the fair value hierarchy. Financial assets do not include amounts due from a government agency as it is a statutory (not contractual) obligation.

Leases

The Company assesses at the inception of a contract whether it contains a lease. A contract is classified as a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company recognizes a right-of-use asset and lease liability at the lease commencement date. The right-of-use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any indirect costs incurred. The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term. The estimated useful lives of right-of-use assets are determined using the same criteria as those for property and equipment. In addition, the right-of-use asset is periodically reduced by impairment losses and adjusted for certain remeasurements of the lease liability, if any.

The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be determined, the Company’s incremental borrowing rate. The lease liability is subsequently increased by the interest cost on the lease liability and decreased by lease payments made. It is remeasured upon a lease modification that is not accounted for as a separate contract or upon a change in the assessment of whether a purchase or extension option is reasonably certain to be exercised or a termination option is reasonably certain not to be exercised. The Company has elected not to recognize right-of-use assets and lease liabilities for short-term leases that have a term of 12 months or less. The Company recognizes the lease payments associated with these leases as an expense on a straight-line basis over the lease term.

 

7


Table of Contents

 

Research and Development

Research and development costs are expensed as incurred in accordance with ASC Topic 730, Research and Development ("ASC 730).

Earnings (Loss) Per Share

Basic earnings (loss) per share is computed by dividing the net earnings (loss) attributable to common shareholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the weighted average number of common shares outstanding is adjusted for the number of shares that are potentially issuable in connection with stock options and warrants (if dilutive). The Company assumes that outstanding dilutive stock options and warrants were exercised and that the proceeds from such exercises (after adjustment of any unvested portion of stock options) were used to acquire Common Shares at the average market price during the reporting periods.

Shareholders’ Equity

Share issuance costs are recorded as a reduction of share capital when the related shares are issued. When shares and liability-classified warrants are issued together as units, the proceeds are first allocated to the warrants at their fair value at the date of issuance, with the residual proceeds allocated to the common shares. The fair value of common shares is based on the market closing price on the date the units are issued and the fair value of share purchase warrants is determined using the Black-Scholes Option Pricing Model as of the date of issuance. When compensation options are issued to agents who refer investors to the Company, their fair value is determined using the Black-Scholes Option Pricing Model as of the date of issuance. The fair value of compensation options is recorded as a reduction of share capital as share issuance costs. When a liability-classified warrant is exercised, the fair value of the warrant liability at the exercise date is reclassified to share capital; when a warrant expires unexercised, the remaining liability is derecognized through the change in fair value of warrant liability.

Share-Based Payments

Share-based payments to employees are measured at the fair value of the instruments issued and recognized over the vesting periods. Share-based payments to non-employees are measured at the grant-date fair value of the equity instruments issued, consistent with awards to employees, in accordance with ASC Topic 718, Compensation—Stock Compensation (“ASC 718”). The fair value of options is determined using the Black-Scholes Option Pricing Model which incorporates vesting conditions. The number of shares and options expected to vest is reviewed and adjusted at the end of each reporting period such that the amount recognized for services received as consideration for the equity instruments granted shall be based on the estimated number of equity instruments that will eventually vest. Over the vesting period, share-based payments are recorded as an operating expense and share capital. When options are exercised, the consideration received is recorded as share capital.

The Company grants RSUs to eligible directors, officers, employees, and consultants of the Company. The fair value of the estimated number of RSUs that will eventually vest, determined at the date of grant, is recognized as share-based payments expense over the vesting period, with a corresponding amount recorded as equity since the Company expects to settle the RSUs with common shares. The fair value of the RSUs is estimated using the market value of the underlying shares as well as assumptions related to the market and non-market conditions at the grant date.

Warrants

The Company determines the accounting classification of warrants it issues as either liability or equity classified by first assessing whether the warrants meet liability classification. Liability classified warrants require fair value accounting at issuance and subsequent to initial issuance with all changes in fair value after the issuance date recorded in the statement of income (loss). Equity classified warrants only require fair value accounting at issuance with no changes recognized subsequent to the issuance date.

Impairment of Long-lived Assets

The Company performs impairment testing on long-lived assets, including property, plant, and equipment, and intangible assets with finite lives, in accordance with ASC Topic 360, Property, Plant, and Equipment (“ASC 360”). Impairment testing is conducted whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Such events or changes in circumstances may include a significant decrease in the market price of a long-lived asset, a significant change in the extent or manner in which an asset is used, a significant change in legal factors or in the business climate, a significant deterioration in the amount of revenue or cash flows expected to be generated from a group of assets, a current expectation that, more likely than not a long-lived asset will be sold or otherwise disposed of significantly before the end of its previously estimated useful life, or any other significant adverse change that would indicate that the carrying value of an asset or group of assets may not be recoverable. The Company performs impairment testing at the asset group level that represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. If events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable and

 

8


Table of Contents

 

the expected undiscounted future cash flows attributable to the asset group are less than the carrying amount of the asset group, an impairment loss equal to the excess of the asset’s carrying value over its fair value is recorded. To date, the Company has not recorded any impairment losses on long-lived assets.

Related Party Transactions

Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control. Related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. The Company did not have any outstanding payable balances with related parties on September 30, 2026.

Contingencies

Contingencies are assessed on an ongoing basis to evaluate the appropriateness of liabilities and disclosures for such contingencies. Liabilities for estimated loss contingencies are recorded when management believes a loss is probable and the amount of the probable loss can be reasonably estimated. Once established, the liabilities are adjusted to the carrying amount of a contingent liability upon the occurrence of a recognizable event when facts and circumstances change, altering previous assumptions with respect to the likelihood or amount of loss. Corresponding assets are recognized for those loss contingencies that are probable of being recovered through insurance. Legal costs are expensed as they are incurred, and with a corresponding asset for such legal costs expected to be recovered through insurance.

Segment Reporting

The Company operates as a single operating and reportable segment because:

•
The Chief Operating Decision Maker (“CODM”), the Company’s Chief Executive Officer, reviews operating results on a consolidated basis.
•
The Company’s activities are focused on the development of extracting lithium compounds from brine, with no distinguishable lines of business or revenue streams.

The Company does not currently generate significant product or service revenues and, therefore, does not have separate segment-level financial information.

Accounting Standards Issued but Not Yet Effective

In November 2024, the FASB issued ASU No. 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40), which requires disaggregated disclosure of specific expense categories in the notes to the financial statements on an interim and annual basis. In January 2025, the FASB issued ASU No. 2025-01 to clarify that this guidance is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted. This ASU is applicable to the Company's fiscal year beginning April 1, 2027 for annual disclosures and April 1, 2028 for interim disclosures. We are currently evaluating the effect of this guidance on our consolidated financial statements.

In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. This ASU updates the cost capitalization threshold for internal-use software development costs by removing all references to software project development stages and providing new guidance on how to evaluate whether the probable-to-complete recognition threshold has been met. This ASU is effective for annual periods beginning after December 15, 2027, and interim periods within those annual reporting periods. This ASU is applicable to our fiscal year beginning April 1, 2028, with early adoption permitted. The transition method may be prospective, modified transition, or retrospective. We are currently evaluating the effect the guidance will have on our consolidated financial statements.

In December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities, which establishes authoritative guidance for business entities on the recognition, measurement, and presentation of government grants. Under the ASU, a government grant is recognized when it is probable that the entity will comply with the conditions attached to the grant and that the grant will be received. Grants related to assets are recognized either as deferred income or as a reduction of the cost basis of the related asset, and grants related to income are recognized in earnings on a systematic basis over the periods in which the entity recognizes the costs the grant is intended to compensate. The ASU is effective for annual periods beginning after December 15, 2028, including interim periods within those annual periods, with early adoption permitted. Transition may be applied on a modified prospective, modified retrospective, or retrospective basis. This ASU is applicable to the Company’s fiscal year beginning April 1, 2029. The Company has not received any government grants as of September 30, 2026. The Company is evaluating potential government grant funding opportunities,

 

9


Table of Contents

 

including programs administered by the U.S. Department of Energy, and is currently evaluating the effect this guidance will have on its consolidated financial statements.

In December 2025, the FASB issued ASU 2025-11 to amend the guidance in Interim Reporting (Topic 270). The amendments in this update clarify current interim disclosure requirements and provide a comprehensive list of required interim disclosures. The update also incorporates a disclosure principle that requires entities to disclose events that occur after the end of the last annual reporting period. This update is effective for interim periods within annual periods beginning after December 15, 2027, though early adoption is permitted. This ASU is applicable to the Company's fiscal year beginning April 1, 2028 and we do not expect it to have a material effect on our consolidated financial statements.

4.
Significant Accounting Judgments, Estimates and Assumptions

The preparation of the Company’s condensed consolidated financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities and contingent liabilities at the date of the condensed consolidated financial statements and reported amounts of income and expenses during the reporting period. Estimates and assumptions are continuously evaluated and are based on management’s experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. However, actual outcomes can differ from these estimates.

Significant judgment, estimates and assumptions that affect reported amounts of assets and liabilities are outlined below:

•
The Company has determined that intangible asset costs incurred which were capitalized have future economic benefits and will be economically recoverable. Management uses several criteria in its assessments of economic recoverability and probability of future economic benefits including anticipated cash flows and estimated economic life. The amortization expense related to intangible assets is determined using estimates relating to the useful life of the intangible asset.
•
The functional currency for the Company and its subsidiaries is the currency of the primary economic environment in which the entity operates. Determination of the functional currency involves certain judgments to determine the primary economic environment and the Company reconsiders the functional currency of its entities if there is a change in events and conditions which determined the primary economic environment. The Company has determined that its functional currency is the United States dollar.
•
The evaluation of the fair value of financial instruments, including the Company’s warrants and options to purchase common shares requires judgment in selecting the appropriate methodologies and models, and evaluating the ranges of assumptions and financial inputs to calculate estimates of fair value.
•
These condensed consolidated financial statements have been prepared on a basis which assumes the Company will continue to operate for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of operations. In assessing whether this assumption is appropriate, management takes into account all available information about the future, which is at least, but not limited to, 12 months from the date of issuance of these condensed consolidated financial statements. This assessment is based upon planned actions that may or may not occur for a number of reasons, including the Company’s own resources and external market conditions.
5.
Accounts Receivable

The Company’s accounts receivables as of September 30, 2026 and March 31, 2026 are as follows (in thousands):

 

 

September 30,

 

 

March 31,

 

 

 

2026

 

 

2026

 

Accounts receivable

 

$

15

 

 

$

70

 

Sales tax refunds

 

 

1

 

 

 

20

 

 

$

16

 

 

$

90

 

The Company had no credit losses for three and six months ended September 30, 2026 and 2025.

 

10


Table of Contents

 

6.
Other Assets

The Company’s other assets as of September 30, 2026 and March 31, 2026 are as follows (in thousands):

 

 

September 30,

 

 

March 31,

 

 

 

2026

 

 

2026

 

Prepaid insurance

 

$

216

 

 

$

66

 

Rental deposit

 

 

17

 

 

 

13

 

Retainers

 

 

58

 

 

 

58

 

Technology licenses

 

 

32

 

 

 

62

 

Other

 

 

62

 

 

 

52

 

Total other assets

 

$

385

 

 

$

251

 

 

7.
Plant and Equipment

The Company’s plant and equipment as of September 30, 2026 and March 31, 2026 are as follows (in thousands):

 

 

September 30,

 

 

March 31,

 

 

 

2026

 

 

2026

 

Existing MDLE Plant

 

$

29,449

 

 

$

29,449

 

Equipment

 

 

921

 

 

 

921

 

Construction in progress

 

 

152

 

 

 

—

 

Office equipment

 

 

42

 

 

 

37

 

 

 

30,564

 

 

 

30,407

 

Less: accumulated depreciation

 

 

4,572

 

 

 

3,565

 

 

$

25,992

 

 

$

26,842

 

 

Depreciation expense for the three months ended September 30, 2026 and 2025 was $0.5 million and $0.5 million, respectively. Depreciation expense for the six months ended September 30, 2026 and 2025 was $1.0 million and $1.0 million, respectively. The MDLE Plant was mobilized to a customer site in June 2024, and depreciation began upon commencement of operations.

8.
Lithium Extraction Technology Asset Purchase and Intangible Assets

On April 12, 2018, the Company closed an asset purchase agreement with North American Lithium, Inc. (“NAL”) and Selective Adsorption Lithium, Inc. (“SAL”), a company formerly controlled by shareholders of NAL, pursuant to which the Company acquired NAL’s data, analysis and reports related to lithium extraction from oilfield brines and all the outstanding shares of SAL, which held certain intellectual property (the “Acquisition”). The consideration for the Acquisition consisted of $875,000 cash, a 5% royalty on future product income, as defined, 4,700,000 common shares at closing and 20,609,488 common shares (“Milestone Shares”) based on the Company achieving certain milestones related to the filing of additional patents and raising additional financing. The total value of the Acquisition, including the Milestone Shares, was valued at approximately $9.1 million and recorded as intellectual property (the, “Intellectual Property”).

Additionally, the Company has filed additional patents to expand its intellectual property for the development of lithium extraction technologies. The Company’s intangible assets as of September 30, 2026, are as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

Gross

 

 

Accumulated

 

 

Net

 

 

Remaining

 

 

 

Assets

 

 

Amortization

 

 

Assets

 

 

Life (Years)

 

Intellectual property

 

$

9,276

 

 

$

(7,632

)

 

$

1,644

 

 

 

1.5

 

Patents

 

 

11

 

 

 

(3

)

 

 

8

 

 

 

15.2

 

 

$

9,287

 

 

$

(7,635

)

 

$

1,652

 

 

 

 

The Company’s intangible assets as of March 31, 2026, are as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

Gross

 

 

Accumulated

 

 

Net

 

 

Remaining

 

 

 

Assets

 

 

Amortization

 

 

Assets

 

 

Life (Years)

 

Intellectual property

 

$

9,276

 

 

$

(7,095

)

 

$

2,181

 

 

 

2.0

 

Patents

 

 

11

 

 

 

(2

)

 

 

9

 

 

15.7

 

 

$

9,287

 

 

$

(7,097

)

 

$

2,190

 

 

 

 

 

 

11


Table of Contents

 

Amortization expense for the three months ended September 30, 2026 and 2025 was $0.3 million and $0.3 million, respectively. Amortization expense for the six months ended September 30, 2026 and 2025 was $0.5 million and $0.5 million, respectively.

9.
Operating Lease

The Company entered into a sub-lease agreement for office space in Plano, Texas, commencing on November 16, 2024, for a term of thirty-four months at an average monthly lease payment of $8,729. The lease liability is calculated using an incremental borrowing rate of 6.83%. Lease costs for the three and six months ended September 30, 2026 and 2025 are as follows (in thousands):

 

 

Three Months Ended September 30,

 

 

Six Months Ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Operating lease costs

 

$

33

 

 

$

26

 

 

$

64

 

 

$

52

 

Variable lease costs

 

 

16

 

 

 

-

 

 

 

28

 

 

 

-

 

Short-term lease costs

 

 

-

 

 

 

4

 

 

 

-

 

 

 

22

 

 

 

$

49

 

 

$

30

 

 

$

92

 

 

$

74

 

The Company has elected not to recognize a lease liability for leases with an expected term of 12 months or less. Additionally, certain variable lease payments are not permitted to be recognized as lease liabilities and are expensed as incurred. Lease balance sheet information as of September 30, 2026 and March 31, 2026 is as follows (in thousands):

 

 

 

 

 

 

September 30,

 

 

March 31,

 

 

 

 

 

 

 

2026

 

 

2026

 

Assets:

 

 

 

 

 

 

 

 

 

 

Operating lease right-of-use asset

 

 

 

 

 

$

93

 

 

$

141

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

Lease obligation, current

 

 

 

 

 

 

104

 

 

 

99

 

Lease obligation, long-term

 

 

 

 

 

 

-

 

 

 

44

 

Total operating lease liabilities

 

 

 

 

 

$

104

 

 

$

143

 

 

10.
Fair Value Measurements

The following table summarizes the Company’s assets and liabilities that are measured at fair value on a recurring basis, by level, with the fair value hierarchy as of September 30, 2026 and March 31, 2026 (in thousands):

 

 

 

September 30, 2026

 

 

 

Fair Value

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liability

 

$

4,749

 

 

$

—

 

 

$

4,749

 

 

$

—

 

 

 

 

March 31, 2026

 

 

 

Fair Value

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liability

 

$

9,968

 

 

$

—

 

 

$

9,968

 

 

$

—

 

 

11.
Shareholders' Equity

Authorized

Authorized share capital: an unlimited number of common shares with no par value.

Issued and Outstanding

On April 29, 2026, the Company and EV Metals (collectively EV Metals VI LLC, EV Metals 7 LLC, EV Metals 8 LLC, and or EV Metals 9 LLC, companies controlled by Jacob Warnock, a director of the Company and a related party), in connection with the 2025 EV Metals Letter Agreement purchased 34,315,465 units priced at $0.08 per unit (CAD$0.109) for gross proceeds to the Company of $2.8 million. Each unit consists of one Common Share and one warrant to purchase a Common Share. Each Warrant, which expires four years from the date of issuance, entitles the holder to purchase one Common Share at a price of CAD$0.148. As part of this offering, the Company paid Mr. Warnock a structuring fee of 5% of the gross proceeds or $0.1 million.

 

12


Table of Contents

 

On February 23, 2026, the Company and EV Metals, in connection with the 2025 EV Metals Letter Agreement purchased 26,427,053 units priced at $0.08 per unit (CAD$0.104) for gross proceeds to the Company of $2.0 million. Each unit consists of one Common Share and one warrant to purchase a Common Share. Each Warrant, which expires four years from the date of issuance, entitles the holder to purchase one Common Share at a price of CAD$0.14. As part of this offering, the Company paid Mr. Warnock a structuring fee of 5% of the gross proceeds or $0.1 million.

On October 30, 2025, the Company and EV Metals, came to an agreement under the 2025 EV Metals Letter Agreement for EV Metals to acquire an additional 12,464,000 units priced at $0.16 per unit (CAD$0.255) for gross proceeds to the Company of $2.0 million. Each unit consists of one Common Share and one warrant to purchase a Common Share. Each Warrant, which expires four years from the date of issuance, entitles the holder to purchase one Common Share at a price of CAD$0.30. As part of this offering, the Company paid Mr. Warnock a structuring fee of 5% of the gross proceeds or $0.1 million.

On July 20, 2025, the Company entered into the Subscription Agreements with certain entities managed or sub managed by Encompass Capital Advisors LLC (“Encompass”), a beneficial owner of more than 5% of the Company’s securities, for the purchase of up to 25,765,259 units at a price of CAD $0.26625 per unit (USD$0.19406 per unit) for gross proceeds of $5.0 million to the Company (the “Encompass Offering”). The 2025 Encompass Offering closed on August 5, 2025. Each 2025 Encompass Unit consists of one Common Share and one warrant, with each warrant entitling the holder to purchase one additional Common Share for a period of three years from the closing date of the 2025 Encompass Offering at an exercise price of CAD$0.355 per share. In addition, the Company has agreed to grant Encompass the right but not the obligation to purchase up to $2.0 million of additional units of the Company at any time on or before December 31, 2025. Encompass did not exercise its right to purchase any additional units of the Company prior to December 31, 2025.

On July 20, 2025, the Company entered into amended and restated registration rights agreements (“A&R Registration Rights Agreements”) which amended the Registration Rights Agreements with each of EV Metals and Encompass. Pursuant to the A&R Registration Rights Agreements, we agreed to use our reasonable best efforts to cause a registration statement to be declared effective as promptly as reasonably practicable but in no event later than July 20, 2026. The Company’s registration statement on Form S-1 was declared effective on February 11, 2026. In addition, pursuant to the Encompass A&R Registration Rights Agreement, upon the closing of the 2025 Encompass Offering we have agreed that, upon request of Encompass, we will use our commercially reasonable efforts to (i) file a registration statement registering the Common Shares to be issued at closing of the 2025 Encompass Offering, including the Common Shares issuable upon exercise of the warrants which form a part of the 2025 Encompass Units within 90 days and (ii) have such registration statement declared effective as promptly as reasonably practicable following the filing thereof but in no event later than 60 days if the registration statement is not reviewed by the SEC or 180 days if subject to review. The A&R Registration Rights Agreements provide that, subject to certain requirements and customary conditions, each of EV Metals and Encompass will have “piggy-back” registration rights with respect to underwritten offerings by us and other shareholders. In addition, upon the request of EV Metals, we have agreed to take necessary steps to facilitate up to two underwritten offerings which must occur prior to the third anniversary of the effective date of the Company's registration statement on Form S-1, or February 11, 2029; provided that the aggregate price of such offering is expected to be $25 million or less.

The A&R Registration Rights Agreements contain customary cross-indemnification provisions, under which we are obligated to indemnify the selling shareholders in the event of material misstatements or omissions in the registration statement and any violation or alleged violation by us of the Securities Act, Exchange Act, or any state securities law, or any rule or regulation thereunder, and the selling shareholders are obligated to indemnify us for material misstatements or omissions attributable to them. We will generally pay all registration expenses in connection with our obligations under the A&R Registration Rights Agreements, regardless of whether any our Common Shares are sold pursuant to a registration statement.

In connection with the foregoing, pursuant to the A&R Registration Rights Agreements, we agreed to extend the expiration date of the warrants previously issued to Encompass and EV Metals pursuant to the private placements which occurred on April 21, 2023, February 29, 2024, May 3, 2024, and June 19, 2024 to the earlier of (i) five years from the date of such warrants original issuance or (ii) three years from the date of the closing of the 2025 Encompass Offering (the “Warrant Amendments”) and each of EV Metals and Encompass has agreed to waive their respective rights to any possible claims, including the right to liquidation damages, under the Registration Rights Agreements provided that the Warrant Amendments are approved by the TSX Venture Exchange ("TSXV").

On February 28, 2025, the Company entered into a letter agreement (the “2025 EV Metals Letter Agreement”) with EV Metals, agreeing to the principal terms and conditions upon which EV Metals, directly or through one or more of its subsidiaries or affiliates, could complete one or more transactions to purchase up to $15.0 million of units (the “2025 Offering”), which each unit (the “2025 Units”) consisting of one Common Share of stock and one warrant to purchase a Common Share. On March 2, 2025, two entities controlled by EV Metals, entered into binding subscription agreements for the purchase of a portion of the 2025 Offering. The first closing of the 2025 Offering occurred on March 31, 2025 for gross proceeds of $7.55 million and the second

 

13


Table of Contents

 

closing of the 2025 Offering occurred on April 11, 2025 for gross proceeds of $679,000, which were reflected in obligation to issue shares as a liability as of March 31, 2025. In connection with the two closings, EV Metals acquired a total of 27,739,348 (25,393,475 in the first closing and 2,345,873 in the second closing) and 690,979 2025 Units, respectively. The pricing of the 2025 Units was CAD $0.4168 per share (USD$0.2894 per share), which was based on the five-day trading average of the Common Shares on the TSXV, less a discount of 25% (the maximum allowable discount permitted by the rules of the TSXV).

The pricing of the 2025 Units was based on the five-day trading average of the common shares on the TSXV for the applicable tranche less the maximum allowable discount permitted by the rules of the TSXV. The warrants included in the 2025 Units will have a term of four years from date of issuance and will entitle the holders to purchase a common share at an exercise price equal to the closing price of the common shares on the TSXV as of the date immediately preceding the date of the news release announcing the 2025 Offering or the closing of the applicable tranche of the 2025 Offering. In connection with the first and second closing of the 2025 Offering, the Company paid structuring fees of $411,450 to Mr. Warnock, a director and control person of EV Metals.

On June 19, 2024, the Company completed another further private placement with EV Metals and Encompass, issuing 8,478,246 units and 3,000,000 units, respectively, for a total of 11,478,246 units and total proceeds of approximately $6.4 million. Each unit consisted of one common share and one common share purchase warrant with each warrant entitling the holder to purchase on additional common share for a period of two years from the date of issuance at an exercise price of CAD$0.9579. The Company agreed to pay Jacob Warnock, a director of the Company and controlling shareholder of EV Metals, a structuring fee of approximately $238,000 which was paid by issuing an additional 423,912 common shares and agreed to cover certain cost incurred in connection with the private placement by Encompass, which was paid in cash totaling $45,000.

On May 6, 2024, the Company completed a further private placement with EV Metals and Encompass, issuing 7,924,157 units and 10,717,977 units, respectively, for a total of 18,642,134 units and total proceeds of approximately $10.4 million. Each unit consisted of one common share and one common share purchase warrant, with each warrant entitling the holder to purchase one additional common share for a period of two years from the date of issuance at an exercise price of CAD$0.9579. The Company agreed to pay EV Metals a structuring fee of approximately $322,000 which was paid by issuing an additional 574,840 common shares and agreed to cover certain costs incurred in connection with the private placement by Encompass, which was paid by issuing an additional 80,385 common shares.

Weighted-average Common Shares Outstanding

(in thousands, except per share amounts)

 

Three Months Ended September 30,

 

 

Six Months Ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Net income (loss)

 

$

2,168

 

 

$

2,978

 

 

$

2,140

 

 

$

4,666

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

 

 

 

Issued common shares at beginning of period

 

 

373,402

 

 

 

271,338

 

 

 

338,434

 

 

 

268,993

 

Effect of common shares issued during period

 

 

989

 

 

 

15,638

 

 

 

29,774

 

 

 

10,066

 

Weighted average number of shares basic

 

 

374,391

 

 

 

286,976

 

 

 

368,208

 

 

 

279,059

 

Assumed exercise of warrants

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Assumed exercise of stock options

 

 

—

 

 

 

—

 

 

 

—

 

 

 

756

 

Assumed restricted share award

 

 

3,758

 

 

 

—

 

 

 

2,900

 

 

 

—

 

Assumed restricted share units

 

 

4,599

 

 

 

4,656

 

 

 

4,599

 

 

 

4,325

 

Weighted average number of shares diluted

 

 

382,748

 

 

 

291,632

 

 

 

375,707

 

 

 

284,140

 

Net income (loss) per share, basic

 

$

0.01

 

 

$

0.01

 

 

$

0.01

 

 

$

0.02

 

Net income (loss) per share, diluted

 

$

0.01

 

 

$

0.01

 

 

$

0.01

 

 

$

0.02

 

Anti-dilutive common share equivalents excluded from the computation of diluted net income per share for the three and six months ended September 30, 2026 and 2025 are as follows (in thousands):

 

 

Three Months Ended September 30,

 

 

Six Months Ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Warrants to purchase common shares

 

 

166,622

 

 

 

97,740

 

 

 

166,622

 

 

 

97,740

 

Options to purchase common shares

 

 

1,300

 

 

 

7,799

 

 

 

1,300

 

 

 

7,042

 

Restricted share units

 

 

7,796

 

 

 

3,700

 

 

 

7,796

 

 

 

4,031

 

 

 

175,718

 

 

 

109,239

 

 

 

175,718

 

 

 

108,813

 

Equity Incentive Plans

On December 17, 2025, the Company adopted the 2025 Omnibus Equity Incentive Plan (the “Omnibus Plan”) which provides for the issuance of up to 49,496,161 Common Shares plus any shares forfeited or cancelled under the Company’s Prior

 

14


Table of Contents

 

Plans (as defined below). Pursuant to the Omnibus Plan, the Company can issue Options, Restricted Share Awards (RSAs), Restricted Share Units (RSUs), Performance Share Units (PSUs), Deferred Share Units (DSUs), Stock Appreciation Rights (SARs) and Dividend-Equivalent Rights.

In addition to the Omnibus Plan, the Company has 6,498,500 options outstanding under the Company’s Rolling 10% Incentive Share Option Plan dated December 15, 2023 (the “Option Plan”), and 6,400,000 RSUs outstanding under the Company’s Amended and Restated Restricted Share Unit Plan dated as of December 17, 2023 (the “RSU Plan” and together with the Option Plan, the “Prior Plans”) Upon the approval of the Omnibus Plan by shareholders, each of the Prior Plans were frozen and no additional awards may be issued under the Prior Plans. Awards outstanding under the Prior Plans will continue to be governed by the terms of the respective Prior Plan.

Stock Options

The Company previously had the “Stock Option Plan" which provided the Company the ability to issue options up to 10% of the number of common shares of the Company issued and outstanding as of each award date, inclusive of all common shares reserved for issuance pursuant to previously granted stock options. Options had a maximum term of ten years from date of issue and vesting was determined by the Board. As of December 17, 2025, there were 6.5 million options outstanding under the Stock Option Plan. Upon adoption of the Omnibus Plan, the Stock Option Plan was frozen and no new options may be issued pursuant to the Stock Option Plan.

The Company has historically issued options utilizing Canadian dollars (CAD$) for the strike price as the Company’s principal public listing of common shares is reported on the TSXV utilizing CAD$. There were no options issued during the six months ended September 30, 2026. The following table summarizes information regarding the options including the historical CAD$ strike prices during the six months ended September 30, 2026:

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

Weighted-

 

 

Average

 

 

 

 

 

 

Average

 

 

Remaining

 

 

 

Options

 

 

Exercise

 

 

Contractual

 

 

 

Outstanding

 

 

Price

 

 

Life (years)

 

 

 

(thousands)

 

 

(CAD$)

 

 

 

 

Balance as of March 31, 2026

 

 

1,300

 

 

$

0.88

 

 

 

2.77

 

Granted

 

 

—

 

 

 

—

 

 

 

 

Expired

 

 

—

 

 

 

—

 

 

 

 

Forfeited

 

 

—

 

 

 

—

 

 

 

 

Balance as of September 30, 2026

 

 

1,300

 

 

$

0.88

 

 

 

2.26

 

The share-based compensation expense for the three months ended September 30, 2026 and 2025 is less than $0.1 million and $0.4 million, respectively. The share-based compensation expense for the six months ended September 30, 2026 and 2025 was less than $0.1 million and $0.1 million, respectively. Share-based compensation is included in selling, general and administrative expenses, excluding depreciation in the condensed consolidated financial statements. There were no proceeds for option exercises during the three and six months ended September 30, 2026 and 2025. As of September 30, 2026, unrecognized compensation expense associated with unvested options granted and outstanding is less than $50 thousand to be recognized over the remaining period of 0.42 years.

Restricted Share Units

The Company previously had the RSU Plan which provided the Company with the ability to issue RSUs covering up to 20,577,824 common shares, inclusive of all common shares reserved for issuance pursuant to previously granted RSUs. Upon adoption of the Omnibus Plan, the RSU Plan was frozen and no new RSUs may be issued pursuant to the RSU Plan.

On June 19, 2026, the Company granted 740,524 RSUs to a member of management. The RSUs vest in equal installments on the first through third anniversary of the grant date. The value of the 740,524 RSUs is $78,000 and will be expensed over the vesting period.

On May 19, 2026, the Company granted 200,000 RSUs to certain employees. The RSUs vest in equal installments on the first through third anniversary of the grant date. The value of the 200,000 RSUs is $19,000 and will be expensed over the vesting period.

On May 14, 2026, the Company granted 2,000,000 RSUs to members of management. The RSUs vest in equal installments on the first through third anniversary of the grant date. The value of the 2,000,000 RSUs is $189,000 and will be expensed over the vesting period.

On February 4, 2026, the Company granted 15,140,352 RSUs to members of management. 2,087,683 of the RSUs vest on the first anniversary of the grant date. The value of the 2,087,683 RSUs is $206,386 and will be expensed over the vesting period all of which were forfeited during the three and six months ended September 30, 2026. 50% of 4,089,298 RSUs shall vest upon the Issuer achieving a $750 million market capitalization over a 60 day volume weighted average trading price and the

 

15


Table of Contents

 

remaining 50% shall vest upon the Issuer achieving $1.5 billion market capitalization over a 60 day volume weighted average trading price. The value of the 4,089,298 RSUs is $295,478 which will be expensed between 2.5 and 3.0 years from the date of grant of which 2,152,262 were forfeited during the three and six months ended September 30, 2026. 50% of 7,963,371 RSUs shall vest upon the Issuer achieving an annualized EBITDA of $25 million and the remaining 50% shall vest upon the Issuer achieving an annualized EBITDA of $50 million of which 4,305,525 were forfeited during the three and six months ended September 30, 2026. The remaining 1,000,000 RSUs will vest in full 60 days following the Issuer's successful listing on a major stock exchange of which 500,000 were forfeited during the three and six months ended September 30, 2026.

On November 3, 2025, the Company granted 50,000 RSUs to a member of management. The RSUs vest in equal installments on the first through third anniversary of the grant date. The value of the 50,000 RSUs is $12,500 and will be expensed over the vesting period.

On October 2, 2025, the Company granted 700,000 RSUs to members of management. The RSUs vest in equal installments on the first through third anniversary of the grant date. The value of the 700,000 RSUs is $241,500 and will be expensed over the vesting period.

On June 2, 2025, the Company granted 2,550,000 RSUs to members of management. 850,000 of the RSUs vest on the first anniversary of the grant date. The value of the 850,000 RSUs is $637,500 and will be expensed over the vesting period. The remaining 1,700,000 RSUs vest upon the Company entering into an executed agreement for the deployment of a second and third MDLE plant.

On April 7, 2025, the Company granted 3,000,000 RSUs to a member of management. 1,000,000 of the RSUs vest on the first anniversary of the grant date. The value of the 1,000,000 RSUs is $550,000 and will be expensed over the vesting period. The remaining 2,000,000 RSUs vest upon the Company entering into an executed agreement for the deployment three MDLE Plants, including the Existing MDLE Plant, these 2,000,000 RSUs were all forfeited during the three and six months ended September 30, 2026.

On February 12, 2025, the Company granted 100,000 RSUs to members of management. The RSUs vest in equal installments on the first through third anniversary of the grant date. The value of the 100,000 RSUs is $49,500 and will be expensed over the vesting period.

During the three months ended September 30, 2026 and 2025 the Company incurred share based compensation expense of approximately zero dollars, net of approximately $150 thousand in forfeitures and $0.4 million, net of no forfeitures, respectively. The share-based compensation expense for all of the RSUs in the six months ended September 30, 2026 and 2025 was approximately $0.2 million, net of approximately $150 thousand in forfeitures, and $0.4 million, net of approximately $320 thousand in forfeitures, respectively.

 

Restricted Share Awards

On December 18, 2025, under the 2025 Omnibus Plan, the Company granted RSAs to certain non-employee members of the Board of Directors with four directors each receiving 1,149,954 RSAs. The closing price on December 18, 2025 was CAD$0.16 and the aggregate value of these RSAs is approximately $517,000. The vesting period for these RSAs is one year and will be expensed over the vesting period. As of September 30, 2026, the Company had 4,599,816 RSAs outstanding under the Omnibus Plan. The share-based compensation expense for the three and six months ended September 30, 2026 was $0.1 million and $0.2 million, respectively, and none during the three and six months ended September 30, 2025.

Warrants

The Company has historically issued warrants utilizing CAD$ for the strike price as the Company’s principale public listing of common shares is reported on the TSXV utilizing CAD$. The following table summarizes information regarding the warrants including the historical CAD$ strike prices during the periods ended September 30, 2026 and 2025:

 

Warrants

 

 

Weighted-
Average
Exercise

 

 

Weighted-
Average
Exercise

 

 

Outstanding

 

 

Price

 

 

Life (years)

 

 

(thousands)

 

 

(CAD$)

 

 

 

 

Balance as of March 31, 2026

 

 

132,306

 

 

$

0.54

 

 

 

2.9

 

Granted

 

 

34,315

 

 

 

0.15

 

 

 

3.6

 

Balance as of September 30, 2026

 

 

166,621

 

 

$

0.46

 

 

 

2.6

 

 

 

16


Table of Contents

 

 

Warrants Outstanding

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Life (Years)

 

 

(thousands)

 

 

(CAD$)

 

 

 

 

Balance as of March 31, 2025

 

 

69,629

 

 

$

0.82

 

 

 

2.2

 

Granted

 

 

28,111

 

 

 

0.37

 

 

 

2.9

 

Balance as of September 30, 2025

 

 

97,740

 

 

$

0.69

 

 

 

2.9

 

As the strike price of the warrants is stated in a currency, Canadian dollars, which is different than the Company’s functional currency, the warrants are treated as a liability in the condensed consolidated balance sheets. The outstanding warrant liability as of September 30, 2026 and March 31, 2026 was approximately $4.7 million and $10.0 million, respectively. During the three months ended September 30, 2026 and 2025, the Company recognized a gain for the change in fair value of the warrants of approximately $5.0 million and $8.8 million, respectively. During the six months ended September 30, 2026 and 2025, the Company recognized a gain for the change in fair value of the warrants of approximately $7.9 million and $14.2 million, respectively. The fair value of the warrants was estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

As of September 30,

 

 

2026

 

2025

 

Risk-free interest rate

 

 

3.5

%

 

 

2.5

%

Expected volatility

 

 

123

%

 

 

120

%

Expected life (years)

 

 

2.6

 

 

 

2.9

 

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

 

12.
Licensing Agreements with Related Parties

In November 2018, the Company entered into licensing agreements as amended with Ensorcia Metals Corporation (“Ensorcia”) and its wholly-owned subsidiaries, Sorcia and Ensorcia Argentina LLC (“EAL”) (collectively, “Ensorcia Group”) whereby the Company issued lithium extraction technology licenses to Sorcia and EAL to use extraction systems manufactured by the Company in exchange for a six percent royalty (6%) on the gross sales price of all products produced and sold, less selling costs, using the licensed technology and a ten percent (10%) participation interest in each of Sorcia’s and EAL’s future resource projects or lithium extraction facilities where the Company’s licensed rights are utilized. The definition of participation interest is to be agreed upon and calculated at the time any future resource projects are negotiated. Pursuant to the licensing agreements, as amended, Sorcia and EAL have a priority over construction of the Company’s next extraction system on the Company’s construction schedule. The Company can terminate the licensing agreements with Sorcia and EAL on or after December 31, 2028. Ensorcia, Sorcia and EAL are related parties of the Company by virtue of significant shareholdings. The controlling shareholder and Chairman of the Ensorcia Group was a director of the Company until October 31, 2024.

On March 30, 2023, the Company and Entec, an affiliate of the Ensorcia Group, entered into the Entec Licensing Agreement. Pursuant to the terms of the Entec Licensing Agreement, the Company will provide Entec with a non-exclusive, limited, world-wide (other than Chile and Argentina) license to access to all patents, trade secrets, and other proprietary rights for use by Entec within the territory solely for the use and operation of equipment and systems manufactured and sold in accordance with the Entec License Agreement for the extraction of lithium salts from lithium bearing raw brine. In consideration for entering the Entec Licensing Agreement, Entec has agreed to provide the Company with a royalty equal to 6% of the net sales with respect to the first resource project or lithium extraction facility utilizing the Company’s licensed technology as well as an interest in the project equal to 10% of Entec’s interest in the project (the “Entec Participation Interest”). With respect to additional resource projects, Entec has agreed to provide the Company with both royalty payments and the Entec Participation Interest equal to the last lithium production agreement entered into by the Company in the country where the project resides.

13.
Employee Benefit Plans

The Company participates in a defined contribution retirement plan sponsored by its professional employer organization (“PEO”). Eligible employees may make voluntary contributions to the plan pursuant to Section 401(k) of the Internal Revenue Code. The Company matches participant contributions up to 3% of eligible compensation, subject to statutory limits. Company matching contributions are expensed as incurred. During the three and six months ended September 30, 2026, the Company expensed $22 thousand and $47 thousand, of matching contributions, respectively. There were no similar contributions during the three months ended September 30, 2025.

 

17


Table of Contents

 

14.
Income Taxes

Provision for Income Taxes

The Company is incorporated in Canada and is subject to Canadian federal and British Columbia provincial income taxes. Because the Company conducts substantially all of its operations through its United States subsidiary — with its operations headquarters in Texas and its initial commercial operations in Utah — the Company is also subject to United States federal income tax and to state and local taxes in the jurisdictions in which it operates, including the Texas franchise (margin) tax and Utah state income tax.

The Company recorded no income tax expense or benefit for the three and six months ended September 30, 2026, or for the three months ended September 30, 2025. The difference between the Company’s effective tax rate of 0% and the combined Canadian federal and British Columbia statutory rate of approximately 27% is primarily attributable to the non-taxable change in the fair value of the warrant liability and changes in the valuation allowance recorded against the Company’s net deferred tax assets.

15.
Commitments and Contingencies

The Company is subject to various claims, assessments, and regulatory requirements arising in the normal course of business. Management assesses the likelihood of any adverse outcomes as well as the range of any potential losses. Where a loss is reasonably possible but not probable, or where the amount cannot be reasonably estimated, no liability is recorded, and the matter is disclosed if material. Management does not believe that the ultimate resolution of any such matters will have a material adverse effect on the Company's condensed consolidated financial statements.

16.
Risk Management

Concentration of Credit risk

Financial instruments that potentially subject the Company to credit risk consist of cash. The Company manages its credit risk relating to cash by dealing only with high-rated financial institutions as determined by rating agencies. As a result, credit risk is considered insignificant. The Company does not consider any of its financial assets to be impaired.

Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulty in meeting obligations associated with financial liabilities. The Company manages liquidity risk by maintaining sufficient cash balances to enable settlement of transactions on the due date. The Company is exposed to liquidity risk. The Company addresses its liquidity by raising capital through the issuance of equity. While the Company has been successful in securing financings in the past, there is no assurance that it will be able to do so in the future.

Foreign currency risk

Foreign currency risk is the risk that a variation in exchange rates between the Canadian dollar and the U.S. dollar will affect the Company’s operations and financial results. The operating results and financial position of the Company are reported in U.S. dollars. As of September 30, 2026, the Company held approximately $146 thousand of Canadian cash and trade payables and other liabilities of $174 thousand denominated in Canadian dollars.

Other risks

Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest rate risk and commodity price risk arising from financial instruments.

17.
Segment Information

The Company operates as a single reportable segment, which reflects the manner in which the CODM manages the business, allocates resources, and evaluates performance. The Company’s activities to date have been limited to research and development and pre-commercialization activities and it has not generated any significant revenue from product sales or services.

Significant Expense Categories

The Company discloses significant segment expense categories that are regularly provided to the CODM. These categories, which represent the major costs incurred in the development of the Company’s technology and operations, are as follows:

 

 

Three Months Ended September 30,

 

 

Six Months Ended September 30,

 

Expense Category

 

2026

 

 

2025

 

 

2026

 

 

2025

 

General and administrative

 

$

1,490

 

 

$

1,784

 

 

$

2,964

 

 

$

4,337

 

Stock-based compensation

 

$

124

 

 

$

413

 

 

$

493

 

 

$

137

 

Other operating expenses

 

$

485

 

 

$

509

 

 

$

894

 

 

$

1,109

 

 

 

18


Table of Contents

 

The CODM reviews these expenses as part of the consolidated financial results. No other measures of segment profit or loss, or assets, are provided to the CODM.

Geographic Information

All operations and assets are located in the United States. As of September 30, 2026, the Company does not have revenue or long-lived assets located outside of the United States.

18.
Subsequent Events

The Company has evaluated subsequent events and transactions occurring after September 30, 2026 through November 16, 2026, the date these condensed consolidated financial statements were issued, and has determined that, except as described below, there were no subsequent events requiring recognition or disclosure in these condensed consolidated financial statements.

On October 2, 2026, the Company granted 600,000 RSUs to certain employees. The RSUs vest in equal installments on the first through third anniversary of the grant date. The value of the 600,000 RSUs is $38,000 and will be expensed over the vesting period.

Debt Financing - Term Sheet

On November 13, 2026, the Company executed a term sheet with EV Metals 10, LLC (a company controlled by Jacob Warnock, a director of the Company and a related party) for a Term Loan of up to $12.0 million. Under the proposed terms, borrowings under the Term Loan would be subject to an Original Issue Discount of 5%, bear interest at 10% per annum, matures 18 months from execution, and be secured by all current and future assets and property of the Company. In the event that the Term Loan is prepaid in the first 12 month, the Company would be subject to a make whole payment on interest assuming the debt was outstanding the entire term of the loan. From months 13 through 18, in the event of a prepayment, the Company would pay a 10% premium on all principal outstanding. EV Metals 10, LLC has committed to fund the facility, subject to the execution of definitive agreements and customary closing conditions, and the parties expect to close the transaction in November 2026. The Company intends to use the proceeds to fund the continued development and deployment of its existing MDLE plant, the construction and deployment of its mobile MDLE pilot plant, and general working capital. As of the date these condensed consolidated financial statements were issued, the financing had not closed. See Note 2, Basis of Presentation — Liquidity and Going Concern.

 

 

 

19


Table of Contents

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following Management’s Discussion and Analysis (“MD&A”) should be read in conjunction with the unaudited condensed consolidated financial statements and the related notes thereto (“Financial Statements”) in Item 1 and the Special Note Regarding Forward-Looking Statements later in this Item 2. All Note references herein refer to the Notes to the Financial Statements. Tabular amounts are displayed in thousands of U.S. dollars except per share and unit count amounts, or as otherwise specifically identified. All references to “CAD$” are to the currency of Canada. Percentages may not recompute due to rounding. You should review the “Risk Factors” set forth in the Company’s Form 10-K filed with the Securities and Exchange Commission on June 17, 2026 for a discussion of important factors that could cause our actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following MD&A.

Overview

We are an advanced technology and manufacturing company focused on exploiting our proprietary and patented technology used in our modular direct lithium extraction plants, or modular direct lithium extraction plant (“MDLE Plant”), to assist owners of lithium brine deposits to extract lithium chloride at sufficient concentration and purity to economically facilitate the production of Lithium Carbonate, an integral component in the manufacture of batteries. Our proprietary and patented MDLE Plant is (1) modular, meaning it can be deployed and then redeployed at a different brine deposit when the resource source is spent and (2) scalable, meaning the component-driven system can specifically configure valves, pumps, our proprietary columns and media and many other pieces to customize the plant to a customer’s requirements based on the needs and resource concentration and that multiple MDLE Plants can be linked together based on the characteristics of the resource location. In addition, our proprietary absorption extraction process is designed to be an environmentally responsible, low-cost method of producing high-quality commercial grade lithium chloride to be converted into Lithium based products.

We believe our MDLE Plants can be utilized by owners on a variety of different brine deposits including, (i) salar or salt lake brine deposits, such as those found in the Lithium Triangle of Argentina, Chile and Bolivia, (ii) brine reservoirs in the US and Canada, including in the US states of North Dakota, Wyoming, Utah, Nevada, Oklahoma, Pennsylvania, Arkansas and Texas (including the Smackover geological formation found in Arkansas and Texas), and (iii) any other naturally occurring lithium brine deposits around the world, including through our collaboration agreement with a major Middle East energy services provider. In addition, we plan to market our technology to industrial customers who have lithium rich brine by-products from their operations. While our Existing MDLE Plant was initially designed for potential customers in the Lithium Triangle, we believe that the US owners of brine reservoirs, especially within the Smackover geological formation in Arkansas and Texas, are currently best positioned to benefit from our existing MDLE Plant. Consequently, we are actively marketing our Existing MDLE Plant and our technology to US and foreign owners of brine reservoirs and anticipate that we will need to spend approximately between $2.0 million and $12.0 million to customize the Existing MDLE Plant to meet the needs of this initial customer depending on the reservoir’s lithium concentration and purity. In addition, we will have costs to transport the MDLE Plant to the new owner. We have not yet delivered MDLE Plants nor licensed our technology to customers and are therefore a pre-revenue company.

Our strategy is to deploy our Existing MDLE Plant and continue to build upon our proprietary DLE technology developed by Dr. John Burba, our founder and Chief Technology Officer, to develop and deploy additional MDLE plants. We believe that our advanced brine extraction technologies and methodologies for selective mineral extraction is less capital intensive and a more environmentally responsible approach compared to traditional lithium extraction processes of hard rock mining and solar evaporation. We believe that this approach is environmentally sustainable because our process does not deconstruct land structures as is the case from hard rock mining nor does it waste precious water as is the case in solar evaporation. Instead, our technology is designed to extract the desired lithium chloride from subsurface brine and typically re-injects the spent or used brine into the aquifer to maintain pressure after lithium extraction.

We are currently in the preliminary stages of researching and developing the media and design for the next generation of our MDLE Plant Technology which we anticipate could provide customers with additional options for processing brine solutions and increasing lithium chloride production. We have recently purchased two larger diameter columns and are currently conducting laboratory and field studies to determine the optimal process for utilizing these columns. We currently estimate that the cost for instrumentation and engineering related to the next generation module and columns of the MDLE Plant will be approximately $500,000 with an additional estimated $250,000 relating to the construction and testing of the larger diameter columns.

Components of the Statement of Operations

Revenue

We generated revenue by testing brine content of potential customers. However, we anticipate generating future revenues through a combination of technology licensing agreements, equipment rentals, constructing MDLE plants and selling them with an associated technology licensing agreement, participation in joint ventures or special purpose entities with resource developers and management fees for overseeing the construction and development of future lithium extraction facilities.

 

20


Table of Contents

 

Operating Costs and Expenses

We operate with a small number of corporate employees to oversee our operations and development with the primary functions including accounting, engineering, fabrication, laboratory, legal, and research being outsourced to third party service providers. This model has allowed us to continue to develop our business and scale the operations as we had funds available. We anticipate that we will add to both our corporate staff and field staff as we commence commercial operations and work to continue developing our technology. To date, we have not experienced any shortages of available employees or outsourced service providers.

Results of Operations

Three months ended September 30, 2026, as compared to the three months ended September 30, 2025

The operating results for three months ended September 30, 2026 and 2025, are summarized as follows (in thousands):

 

 

Three Months Ended September 30,

 

 

2026

 

 

2025

 

REVENUE

 

 

 

 

 

 

Service

 

$

-

 

 

$

64

 

Total revenue

 

 

-

 

 

 

64

 

 

 

 

 

 

 

 

COST OF REVENUE

 

 

 

 

 

 

Service

 

 

-

 

 

 

11

 

Total cost of revenue

 

 

-

 

 

 

11

 

Gross margin

 

 

-

 

 

 

53

 

 

 

 

 

 

 

 

OPERATING COSTS AND EXPENSES

 

 

 

 

 

 

Operating costs, excluding depreciation

 

 

485

 

 

 

509

 

Selling, general and administrative expenses, excluding depreciation

 

 

1,614

 

 

 

2,197

 

Amortization of intangible assets

 

 

269

 

 

 

269

 

Depreciation

 

 

504

 

 

 

504

 

Operating loss

 

 

(2,872

)

 

 

(3,426

)

Loss on warrants modification

 

 

-

 

 

 

(2,444

)

Change in fair value of warrant liability

 

 

5,042

 

 

 

8,848

 

Other income (expense)

 

 

(2

)

 

 

-

 

Net income (loss)

 

$

2,168

 

 

$

2,978

 

Revenue

There was no revenue during the three months ended September 30, 2026. During the three months ended September 30, 2025 we generated testing revenue on brine content for a potential customer.

Operating Cost, excluding depreciation

For the three months ended September 30, 2026 and 2025, we incurred operating costs of $0.5 million and $0.5 million, respectively, the slight decrease in costs are due to lower testing costs for the three months ended September 30, 2026.

 

21


Table of Contents

 

Selling, General And Administrative Expenses

The major components of selling, general and administrative expenses for the three months ended September 30, 2026 and 2025, are as follows (in thousands):

 

Three Months Ended September 30,

 

 

2026

 

 

2025

 

Compensation expense

 

$

682

 

 

$

795

 

Share-based compensation

 

 

124

 

 

 

413

 

Professional fees

 

 

194

 

 

 

410

 

Legal fees

 

 

270

 

 

 

268

 

Rent and miscellaneous office

 

 

256

 

 

 

225

 

Other

 

 

88

 

 

 

86

 

 

$

1,614

 

 

$

2,197

 

Compensation expense decreased compared to the prior period primarily due to a reversal of certain compensation accruals that are no longer payable as of September 30, 2026.

Share-based compensation decreased for the three months ended September 30, 2026 as there was a large forfeiture of stock awards due to the changes in the executive management team that occurred during the three months September 30, 2026.

Professional fees decreased compared to the prior period primarily due to accounting and auditing fees incurred in the prior-year period in connection with the filing of our registration statement.

Legal fees were consistent with the prior-year period.

Rent and miscellaneous office costs increased compared to the prior year period due to additional costs for our Houston office.

Other expenses were consistent with the prior-year period.

Gain/Loss on Warrants Modification

For the three months ended September 30, 2026, the Company did not have any modifications of the warrants which led to a gain or loss. For the three months ended September 30, 2025, the Company modified some of it warrants which led to a loss of $2.4 million.

Changes in Fair Value of Warrant Liability

The Company values the outstanding warrant liabilities at each balance sheet date based on the Black-Scholes option pricing model. Any change in the fair value of the warrants is recognized as a change in fair value of warrant liability in the condensed consolidated statement of income (loss). During the three months ended September 30, 2026, the Company recognized a gain of approximately $5.0 million as compared to approximately $8.8 million for the three months ended September 30, 2025, for the change in fair value of warrant liability during the period. The primary reason for the decrease in the warrant liability valuation was the decline in our share price and the shorter remaining expected life of the outstanding warrants.

 

22


Table of Contents

 

Six months ended September 30, 2026, as compared to the six months ended September 30, 2025

The operating results for the six months ended September 30, 2026 and 2025, are summarized as follows (in thousands):

 

 

Six Months Ended September 30,

 

 

 

2026

 

 

2025

 

REVENUE

 

 

 

 

 

 

Service

 

$

120

 

 

$

71

 

Total revenue

 

 

120

 

 

 

71

 

 

 

 

 

 

 

COST OF REVENUE

 

 

 

 

 

 

Cost of revenue

 

 

3

 

 

 

12

 

Gross margin

 

 

117

 

 

 

59

 

 

 

 

 

 

 

OPERATING COSTS AND EXPENSES

 

 

 

 

 

 

Operating costs, excluding depreciation

 

 

894

 

 

 

1,109

 

Selling, general and administrative expenses, excluding depreciation

 

 

3,457

 

 

 

4,474

 

Amortization of intangible assets

 

 

538

 

 

 

538

 

Depreciation

 

 

1,007

 

 

 

1,002

 

Operating loss

 

 

(5,779

)

 

 

(7,064

)

Loss on warrants modification

 

 

-

 

 

 

(2,444

)

Change in fair value of warrant liability

 

 

7,925

 

 

 

14,171

 

Other income (expense)

 

 

(6

)

 

 

3

 

Net income (loss)

 

$

2,140

 

 

$

4,666

 

Revenue

For the six months ended September 30, 2026 we generated testing revenue on brine content for three potential customers. For the comparative period ended September 30, 2025, we generated revenue testing brine content from two potential customers.

Operating Cost, excluding depreciation

For the six months ended September 30, 2026 and 2025, we incurred operating costs of $0.9 million and $1.1 million, respectively. The decrease in costs is primarily due to lower research and development costs during the six months ended September 30, 2026.

 

23


Table of Contents

 

Selling, General And Administrative Expenses

The major components of selling, general and administrative expenses for the six months ended September 30, 2026 and 2025, are as follows (in thousands):

 

Six Months Ended September 30,

 

 

2026

 

 

2025

 

Compensation expense

 

$

1,498

 

 

$

2,171

 

Share-based compensation

 

 

493

 

 

 

137

 

Professional fees

 

 

431

 

 

 

910

 

Legal fees

 

 

418

 

 

 

685

 

Engineering

 

 

0

 

 

 

0

 

Rent and miscellaneous office

 

 

454

 

 

 

397

 

Other

 

 

163

 

 

 

174

 

 

$

3,457

 

 

$

4,474

 

Compensation expense decreased compared to the prior period primarily due to large severance payments in the prior six months ended September 30, 2025 offset by higher payroll during the six months ended September 30. 2026 due to hiring full time employees compared to contractors and consultants.

Share-based compensation increased for the six months ended September 30, 2026 as there were forfeitures of stock awards due to the changes in the executive management team that occurred during both the six months ended September 30, 2026 and 2025, which was higher in the prior year. In addition, the increase is due to a larger overall number of stock based grants during the six months ended September 30, 2026.

Professional fees decreased compared to the prior period primarily due to accounting, auditing and other consultant fees incurred in the prior-year period in connection with the filing of our registration statement.

Legal fees decreased as compared to the prior period as a result of the timing of the changes to executive management and additional work that was incurred related to the registration statement activities.

Rent and miscellaneous office costs increased compared to the prior year period due to additional costs for our Houston office.

Other expenses decreased minimally as compared to the prior year period.

Loss on Warrants Modification

For the six months ended September 30, 2026, the Company did not have any modifications of the warrants which led to a gain or loss. For the six months ended September 30, 2025, the Company modified some of it warrants which led to a loss of $2.4 million.

Changes in Fair Value of Warrant Liability

The Company values the outstanding warrant liabilities at each balance sheet date based on the Black-Scholes option pricing model. Any change in the fair value of the warrants is recognized as a change in fair value of warrant liability in the condensed consolidated statement of income (loss). During the six months ended September 30, 2026, the Company recognized a gain of approximately $7.9 million as compared to approximately $14.2 million for the six months ended September 30, 2025, for the change in fair value of warrant liability during the period. The primary reason for the decrease in the warrant liability valuation was the decline in our share price and the shorter remaining expected life of the outstanding warrants, partially offset by the addition of the warrants issued in the April 2026 private placement.

Liquidity and Capital Resources

These condensed consolidated financial statements have been prepared on a going concern basis which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. As of September 30, 2026, the Company had an accumulated deficit of approximately $37.3 million and working capital of approximately $7.9 million. During the six months ended September 30, 2026, the Company raised additional cash in a private placement totaling $2.8 million. The Company raised approximately $9.0 million through four private placements during the year ended March 31, 2026.

 

24


Table of Contents

 

Material Cash Requirements

Over the next twelve months, we expect our primary cash requirements to be (i) funding operating losses, (ii) the continued development and deployment of our existing MDLE plant, and (iii) the construction and deployment of a mobile MDLE pilot plant, which we currently estimate will require approximately $4 million in total. We will also incur interest and other debt service obligations under the debt facility described below once it closes.

1.
Debt Financing

On November 13, 2026, we executed a term sheet with EV Metals 10, LLC (a company controlled by Jacob Warnock, a director of the Company and a related party) for a senior secured debt facility of up to $12 million, which we expect to close in November 2026. EV Metals 10, LLC has committed to fund the facility, subject to the execution of definitive agreements and customary closing conditions. We intend to use the proceeds to fund the development and deployment of our existing MDLE plant, the construction and deployment of our mobile MDLE pilot plant, and general working capital.

2.
Going Concern

Without additional financing, our existing cash and working capital would not be sufficient to fund our planned operating and capital expenditures for at least one year from the date of issuance of our condensed consolidated financial statements, and these conditions raised substantial doubt about our ability to continue as a going concern. We believe it is probable that the debt financing will be completed and that the proceeds, together with our existing cash and working capital, will be sufficient to fund our operating and capital requirements for at least that period. Accordingly, management has concluded that these plans alleviate the substantial doubt. However, the financing has not yet closed, and there can be no assurance that it will be completed on the anticipated terms or timeline, or at all. We expect to require additional financing in the future to fund our operations and growth, and there can be no assurance that such financing will be available on acceptable terms, or at all. See Note 2 to our condensed consolidated financial statements.

Summary of Cash Flows

The cash flows for the six months ended September 30, 2026 and 2025, are as follows (in thousands):

 

 

Six Months Ended September 30,

 

 

 

2026

 

 

2025

 

Cash used in operating activities

 

$

(4,364

)

 

$

(5,761

)

Cash used in investing activities

 

 

(41

)

 

 

(359

)

Cash provided by (used in) financing activities

 

 

2,597

 

 

 

4,806

 

Net change in cash

 

$

(1,808

)

 

$

(1,314

)

Operating Activities

Cash used in operating activities for the six months ended September 30, 2026 was approximately $4.4 million as compared to $5.8 million for the six months ended September 30, 2025. The decrease compared to prior period is mostly due to lower operating expenses in the six months ended September 30, 2026 mostly as a result of lower operating costs as well as less severance costs.

Investing Activities

Cash used in investing activities for the six months ended September 30, 2026 decreased compared to the six months ended September 30, 2025 as the prior-year period included purchases to complete the MDLE Plant build-out.

Financing Activities

Cash provided by financing activities for the six months ended September 30, 2026 decreased compared to prior period, as we raised net proceeds of $2.8 million for the proceeds of a private placement during the six months ended September 30, 2026, compared with $4.8 million for the proceeds of private placements during the six months ended September 30, 2025.

 

25


Table of Contents

 

Critical Accounting Estimates

There were no material changes to our critical accounting estimates from those disclosed in our Form 10-K filed with the Securities and Exchange Commission on June 17, 2026.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements and we do not contemplate having them in the foreseeable future.

Financial Instruments and Other Instruments

The carrying values of cash, accounts receivable, trade payables and other liabilities and lease liability approximate their fair values because of the short-term maturity of these financial instruments. We have no exposure to asset backed commercial paper.

Accounting Policies

A detailed summary of all the Company’s significant accounting policies is included in Note 3 to the audited consolidated financial statements for the year ended March 31, 2026, found in our Form 10-K filed with the Securities and Exchange Commission on June 17, 2026.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We have not entered into any market risk sensitive instruments for trading purposes. We are exposed to market risks in the ordinary course of business including fluctuations in interest rates and commodity prices, which can affect our operating, investing, and financing activities.

Special Note Regarding Forward-Looking Statements

Certain information contained in this quarterly report, including information regarding future financial and operational performance and plans, targets, aspirations, expectations, and objectives of management, constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act and forward-looking information within the meaning of applicable Canadian provincial and territorial securities laws. We refer to all of these as forward-looking statements. Forward-looking statements are forward-looking in nature and, accordingly, are subject to risks and uncertainties. All statements other than statements of historical fact included in this quarterly report regarding the prospects of the Company’s industry or its prospects, plans, financial position or business strategy may constitute forward-looking statements. In addition, forward-looking statements generally can be identified by the use of forward-looking words such as “plans,” “expects,” “does not expect,” “is expected,” “look forward to,” “budget,” “scheduled,” “estimates,” “forecasts,” “will continue,” “intends,” “the intent of,” “have the potential,” “anticipates,” “does not anticipate,” “believes,” “should,” “should not,” or variations of such words and phrases that indicate that certain actions, events or results “may,” “could,” “would,” “might,” “will,” “be taken,” “occur,” “be achieved,” or the negative of these terms or variations of them or similar terms and include, without limitation, statements regarding our expectations or beliefs regarding:

•
our expectations regarding industry demand for lithium;
•
our beliefs regarding demand for our current MDLE Plant and MDLE Plant technology and that our MDLE Plant can be utilized by owners on a variety of different brine deposits;
•
our strategies for attracting customers and deploying our MDLE Plant;
•
our beliefs regarding the current MDLE Plant and the next generation of MDLE Plant technology, including our belief that it is less capital intensive and a more environmentally responsible than traditional lithium extraction processes;
•
our expectations regarding potential customers for our MDLE Plant;
•
expectations regarding the potential customizations that may be required for our MDLE Plant, the operational impact of such customizations and the cost, and our ability to fund, such customizations;
•
our future strategies for developing revenue streams and our other financial and operational strategies;
•
our expectations regarding the amount and timing of our future financing requirements and fund raising process;
•
the impact of compliance with applicable laws and regulations, including environmental laws, and various legal proceedings on our financial results and future business prospects;
•
our ability to continue as a going concern and our plans to obtain additional financing; and
•
the impact of certain tax and accounting matters, including estimates, on our financial statements.

Our forward-looking statements, included in this quarterly report and elsewhere, represent management’s expectations as of the date that they are made and we undertake no obligation to update these statements. Our forward-looking statements are based on assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, these forward-looking statements are subject to a number of risks and uncertainties and actual results may differ materially from those expressed or implied in such statements. Important factors that could cause actual results, level of activity, performance or

 

26


Table of Contents

 

achievements to differ materially from those expressed or implied by these forward-looking statements include those risks set forth in our SEC filings and risks related to:

•
our ability to obtain adequate or timely funding to operate our business and meet our future capital expenditure requirements;
•
industry demand and market prices for lithium;
•
our ability to attract and negotiate a definitive agreement with a customer for our current MDLE Plant;
•
our ability to customize the MDLE Plant to meet the needs of a customer, including our ability to fund such customizations;
•
our ability to protect our intellectual property rights in our technology;
•
the success or failure of management’s efforts to continue to develop the next generation of our MDLE Plant technology;
•
rapid technological change that could cause our technology to become obsolete or not cost-effective;
•
the loss of key members of our management team; and
•
our ability to expand in existing and new markets.

 

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act, consisting of controls and other procedures designed to give reasonable assurance that information we are required to disclose in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to management, including our Interim Chief Executive Officer and our Chief Financial Officer, to allow timely decisions regarding such required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our Interim Chief Executive Officer and Chief Financial Officer have evaluated such disclosure controls and procedures as of the end of the period covered by this quarterly report on Form 10-Q and have determined that such disclosure controls and procedures are effective.

Changes in internal control over financial reporting.

There was no change in our internal control over financial reporting during the quarter ended September 30, 2026 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

27


Table of Contents

 

PART II—OTHER INFORMATION

Item 1A. RISK FACTORS

There were no material changes to the risk factors disclosed in Part I, Item 1A "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended March 31, 2026, filed with the SEC on June 17, 2026.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

None.

Item 5. Other Information.

10b5-1 Trading Plans

During the three months ended September 30, 2026, none of our officers (as defined in Rule 16a-1(f) of the Exchange Act) or directors adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

 

28


Table of Contents

 

Item 6. Exhibits.

 

Exhibit

Number

Description

10.48*+

 

Interim CEO Letter Agreement, dated July 24, 2026 between the Company and James Garrett Galloway

31.1*

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*

Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

101.SCH

 

Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.

+ Indicates management contract or compensatory plan.

(1) Incorporated by reference to the Company’s Form 8-K on April 29, 2026 (No. 333-286616).

 

 

29


Table of Contents

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

International Battery Metals Ltd.

 

 

Date:

November 16, 2026

By:

/s/ Donald Bender

 

 

Name: Donald Bender

 

 

Title: Interim Chief Executive Officer

 

 

Date:

November 16, 2026

By:

/s/ Michael Rutledge

 

 

 

 

Name: Michael Rutledge

 

 

 

 

Title: Chief Financial Officer

 

 

30


Keep reading